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The correct insertion of membrane proteins is essential for the normal functioning of a 
eukaryotic cell, and different classes of membrane proteins employ different mechanisms 
of insertion into their target membrane. One of these pathways is the GET pathway, which 
promotes the insertion of tail-anchored proteins into the ER membrane. Tail-anchored 
protein substrates of this pathway are then involved in trafficking, metabolism, or protein 
translocation in the cell. The key players of the pathway in mammals are the cytosolic 
ATPase TRC40 and the heterodimeric receptor at the ER membrane consisting of CAML 
and WRB. Recent studies showed a second function for the yeast homologue of TRC40, 
Get3, to not only work in tail-anchored protein targeting, but also as an ATP-independent 
chaperone under oxidative stress conditions. While the pathway is not essential in yeast, 
loss of some of its main components results in early embryonic lethality in mice, but the 
reason for this is so far not fully understood. In this study, a mouse model was established 
to further elucidate the role of the mammalian GET pathway in vivo. The model allows a 
deletion of the middle exons of WRB in a hepatocyte-specific manner by using the Cre-
Lox system, leading to an impairment of the pathway in the liver, a tissue that is high in 
secretion, protein biosynthesis and trafficking. The results obtained show that this deletion 
leads to severe liver damage in mice, which was evident in situ, as well is in liver enzyme 
levels in the blood and increasing fibrosis in the organs, shown by histological analysis. 
The liver damage changed from an acute state to a more chronic damage with increasing 
age of the animals. Furthermore, the massive damage and loss of hepatocytes led to 
subsequent liver regeneration. At the stage of acute liver damage, some of the substrates 
of the mammalian GET pathway were shown to be affected by the disturbance of the 
pathway. The protein levels of Syntaxin5 and Syntaxin6, two SNAREs, were decreased in 
hepatocytes, and Stx5 displayed a clear loss of targeting to the Golgi membrane in 
hepatocytes. In conclusion, the study shows that a targeted disruption of WRB in 
hepatocytes severely impairs liver function and integrity, and some substrates of the 
mammalian GET pathway show a higher susceptibility to this impairment than others.  
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1.1 Cellular compartments and the secretory pathway 
Every eukaryotic cell is composed of several distinct compartments, all of which differ in 
their functions and along with this in their biochemical properties. All of these 
compartments together master the various processes that take place in the cell, from the 
different biosynthesis pathways to metabolic tasks, signalling or secreting. Depending on 
the cell-type, some of these functions are more prominent than others. To allow every 
compartment to perform its functions with the biochemical and biophysical conditions 
needed, and to allow separation of processes, the different compartments are enclosed 
by biomembranes. However, by one way or another, these membranes stay on close 
contact to each other, giving rise to the endomembrane system. In the eukaryotic cell, 
organelles forming endomembrane system are the membranes of the nucleus, the 
Endoplasmic Reticulum (ER), the Golgi apparatus, lysosomes, endosomes and vesicles. 
The plasma membrane is surrounding this whole system, as the outmost border of the cell 
(Alberts, 2008). 
The membranes of this system carry individual biochemical signatures that mark the 
specific compartment the membrane encloses. This unique signature consists amongst 
others of both lipid as well as protein composition (as reviewed in e.g. Mellman and 
Warren, 2000; van Meer et al., 2008) and allows a directed and specific interchange 
between the different compartments of the eukaryotic cell. In general, traffic in cells can 
occur in two distinct directions: In the endocytic pathway, cargo is transported from the 
plasma membrane into the cell, whereas in the secretory pathway, cargo is transported 
towards the plasma membrane and finally secreted from the cell. This traffic between 
different compartments, such as the Golgi apparatus, the Endoplasmic Reticulum (ER) or 
the endosomes, is enabled by vesicles carrying the cargo. To ensure that this transport in 
the cell is targeted is role of the above-mentioned markers, which are also found on the 
vesicles. Cargo receptors are located in the membrane of the individual compartments 
and bind to specific cargo. The adaptor proteins bind to the receptors as well as to the 
coating proteins, and this whole process allows the formation of small vesicles, in whose 
membrane the cargo, bound to the receptor, is enriched. With the help of the coating 
protein, the vesicles can reach their typical vesicular shape, and finally be released from 
their originating compartment and perform their function in trafficking. Upon reaching the 
target membrane, the coat is then disassembled, the vesicle fuses with the target 
membrane and the cargo is released (Mellman and Warren, 2000). 
Depending on the direction of trafficking and the originating compartment, different coated 
vesicles are responsible for the transport. The main characterised ones are Clathrin 
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coated vesicles, which predominantly form on the plasma membrane, endosomes and the 
trans-Golgi network, COPI vesicles, which can carry ER resident proteins back to the ER 
from the Golgi, and COPII vesicles, which form on the ER and carry their cargo to the 
Golgi (reviewed in Barlowe and Miller, 2013; Mellman and Warren, 2000). 
After the correct formation of vesicles on the donor compartment, the next task of the cell 
is to ensure for the vesicle to reach its destined target compartment. The process of 
targeting and then fusion is mediated by a set of proteins on both the vesicle and the 
target membrane. One group of proteins playing a major role in both tethering and fusion 
are the so called soluble N-ethylmaleimide-sensitive factor attachment protein receptors 
(SNAREs) (Jahn and Scheller, 2006). They allow the last steps in vesicle trafficking, which 
are the fusion of the vesicle with the target membrane and thus allowing the release of the 
cargo. SNAREs are transmembrane proteins and can be found on both the vesicle and 
target compartment, and by being distributed in specific subsets, they add to the 
specificity in targeting (Jahn and Scheller, 2006). 
 
1.2 Membrane proteins 
In both the compartmentalisation and trafficking within the cell, membrane proteins are 
indispensable for the cell. They allow transport and exchange between the different 
compartments and the cytosol and fulfil a remarkable variety of roles, for example in 
enzymatic processes, signalling, trafficking or energy supply. Membrane proteins come in 
a lot of different flavours regarding their topology and structure.  
In general one can separate membrane proteins into two groups, depending on how they 
are associated with the membrane. The group of peripheral membrane proteins does not 
actually penetrate the membrane, but is peripherally linked to the membrane, e.g. by 
means of a lipid anchor, non-covalent interactions with other membrane proteins, lipids or 
an oligosaccharide connected to the protein. The group of integral membrane proteins on 
the other hand is incorporated into the membrane with a hydrophobic part of the protein, 
the transmembrane domain (TMD). Again two subgroups can be described. It is possible 
that the protein does not actually span the full bilayer, but is only integrated in one part of 
the bilayer. These proteins belong to the group of integral monotopic proteins. 
Transmembrane proteins, the second subgroup of integral membrane proteins, span the 
full bilayer with either one or more hydrophobic transmembrane domains (Alberts, 2008). 
 
1.2.1 Different topologies of transmembrane proteins 
When a protein spans the membrane with one or more transmembrane domains, its 
orientation with regard to the cytosol may vary. Depending on how the transmembrane 
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protein is integrated and where the N-Terminus of the protein resides, different types of 
proteins are described. Since the nomenclature or classification has been continually 
changing during the last years it should be mentioned that the one described here is the 
one that is used on uniprot.org and in (Chou and Shen, 2007). Here, only the first four 
types of transmembrane proteins are briefly introduced. Type I transmembrane proteins 
face the organelle lumen with their N-terminus while their C-terminus faces the cytosol. 
They possess both a cleavable signal sequence and stop-transfer sequence that remains 
in the membrane as a single transmembrane domain. Type II and Type III transmembrane 
proteins do not have a cleavable signal sequence, but only a signal anchor sequence that 
functions both in targeting and as the single transmembrane domain. Type II 
transmembrane proteins have an N-terminus facing the cytosol, whereas Type III 
transmembrane proteins show the opposite orientation. The orientation of the protein in 
the membrane depends on the charge of the amino acids flanking the signal anchor 
sequence and follows the “positive inside rule”, meaning that positively charged amino 
acids in the flanking regions are mainly found on the cytosolic side (Hartmann et al., 1989; 
Heijne and Gavel, 1988). Like Type I-III, Type IV transmembrane proteins only have a 
single transmembrane domain that acts as signal sequence and membrane anchor. This 
domain is located at the very C-terminus, leading to the term Tail-Anchored proteins (TA 
proteins) (Borgese et al., 2003; Kutay et al., 1993). Their N-terminus faces the cytosol, 
while their C-terminus is luminal. This last class of proteins are the main focus of this 
study and their features and biogenesis will be described in more detail in the next 
subchapter. 
 
1.2.2 Tail-Anchored proteins 
Tail-Anchored proteins differ from all other membrane proteins by their very unique 
topology. Their single transmembrane domain is located at the very C-terminus of the 
protein, meaning that the transmembrane domain lies within the last 50 residues of the 
primary sequence and usually not more than ~30 residues follow in the protein sequence 
after the transmembrane domain (Borgese et al., 2003; Kutay et al., 1993). They cover a 
wide range of functions and can be found at various membranes in the eukaryotic cell. 
Some examples are Cytochrome b5 or UBC6 at the ER, both performing enzymatic 
functions, or SNARE proteins, which act in vesicular fusion. Other TA proteins act in 
protein translocation or regulation of Apoptosis (Borgese et al., 2003). In a bioinformatic 
study, it was suggested that more than 400 TA proteins are encoded in the human 




1.3 Targeting and membrane insertion of transmembrane proteins in 
the eukaryotic cell 
Since transmembrane proteins fulfil many essential functions in the cell, it is important to 
ensure correct targeting and insertion of the protein into the membrane of its destined 
compartment. The cell must recognise the protein as a transmembrane protein during 
synthesis, and the protein has to be targeted correctly to the right localisation in the cell. 
After reaching its target membrane, correct insertion has to be ensured as well. 
In the eukaryotic cell, two basic mechanisms can be distinguished. Proteins can either be 
inserted into the membrane in a co-translational manner, with translation and translocation 
taking place at the same time at the target membrane, or proteins are targeted to and 
inserted into their target membrane in a post-translational manner after protein synthesis 
has been finished. The structure and topology of the protein mainly determines the way of 
insertion, but also its target. Direct import into mitochondria, peroxisomes, the nucleus and 
chloroplasts happens in a post-translational manner, whereas transport into the ER 
membrane can take place in both forms. 
According to current hypotheses, the co-translational pathway has evolved later and 
presents a more complex and advanced mechanism for protein insertion (Cross et al., 
2009). 
 
1.3.1 Co-translational protein insertion into the ER membrane 
Many membrane proteins are first inserted into the ER membrane, and either stay there 
as ER resident proteins or reach their final destination via vesicle transport. The signal 
that guides proteins to the ER membrane is given by either the cleavable signal sequence 
in type I or multispanning proteins, or the signal anchor sequence in type II and type III 
proteins. The factor responsible for recognising either the signal sequence or the signal 
anchor sequence is the Signal Recognition Particle (SRP), and binding of the SRP to the 
hydrophobic signal or signal anchor sequence takes place during active translation. Due 
to this interaction between the SRP and the ribosome, further elongation is slowed down 
and translation is stalled (Halic et al., 2004). This allows the complex of the ribosome 
nascent chain and the SRP to be targeted to the ER membrane, where the SRP binds to 
the SRP receptor (SR), an ER membrane protein consisting of the two subunits SRα and 
SRβ (Gilmore et al., 1982a; 1982b; Montoya et al., 1997; Tajima et al., 1986). The SRP as 
well as the two SR subunits are active GTPases (Connolly and Gilmore, 1989; Miller et 
al., 1995; 1993), and GTP binding and hydrolysis acts as the driving force for the steps in 
targeting and transferring the RNC to the translocon. After GTP hydrolysis, SRP is 
released from SR and can engage in another targeting process. 
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The following translocation of the protein across the ER membrane takes place via the 
Sec61 translocon. This complex consists of three subunits: α, β and γ. The α-subunit is 
the actual pore-forming unit while β and γ act as accessory factors(Mothes et al., 1994). 
The Sec61 complex works as the main receptor for the ribosome at the ER membrane 
(Kalies et al., 1994; Prinz et al., 2000b), and upon binding, the ribosome exit tunnel and 
the pore formed by the Sec61 translocon fully align, thus allowing translocation of the 
emerging protein (Becker et al., 2009; Beckmann et al., 1997; Prinz et al., 2000a). 
 
1.3.2 Post-translational insertion of Tail-Anchored proteins into the ER membrane 
TA proteins strongly differ from other transmembrane proteins in their topology, as their 
single transmembrane domain is located only within the last 50 residues of the protein and 
not more than ~30 residues following the TMD (Borgese et al., 2003; Kutay et al., 1993). 
During translation of TA proteins, the TMD stays in the ribosome machinery until the very 
end of translation, making it impossible for the SRP machinery to bind to the TMD before 
the end of translation. This prohibits a co-translational translocation, implicating that TA 
proteins can insert only post-translationally (Borgese and Fasana, 2011; Kutay et al., 
1995). 
TA proteins have different target membranes and are inserted into the ER, peroxisomes, 
mitochondria and chloroplasts, always via post-translational pathways (Borgese and 
Fasana, 2011). The following part will mainly discuss the insertion into to ER, since many 
TA proteins first insert into the ER and are only later exported to their final target 
organelle. Insertion into the ER can, at least in vitro, happen via two general ways. 
Proteins can either insert unassisted into the ER membrane, or in a Chaperone-mediated 
manner. 
For unassisted insertion, cytochrome b5 (b5) is the best-characterised substrate TA 
protein. It has been subject of many studies and was shown to insert in vitro into a lipid 
bilayer without any cytosolic or membrane protein assisting, but already small amounts of 
cholesterol in the target membrane prevent insertion (Brambillasca et al., 2005; Colombo 
et al., 2009). Further studies revealed that the capacity of b5 to insert unassisted is 
promoted by the moderate hydrophobicity of its TMD. If the TMD of Synaptobrevin 2 
(Syb2), another TA protein not displaying this feature, was substituted for the TMD of b5, 
this was sufficient to promote unassisted insertion of Syb2. This effect can also be 
observed in the inverse way, making b5 incapable of spontaneous insertion if its TMD is 
replaced by the one of Syb2 (Brambillasca et al., 2006).  
In vivo, the most crucial step is for each TA protein to reach its destined organelle by way 
of correct targeting. Since hydrophobic patches of proteins are very aggregation-prone in 
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the cytosolic environment, chaperones are needed to keep the TA proteins in an insertion-
competent state until they reach the correct target membrane. The involvement of 
chaperones is also likely since research has already early shown the ATP dependency of 
insertion of some TA proteins such as Syb2 (Kutay et al., 1995). 
Several chaperones have been associated with TA protein targeting and insertion. The 
SRP has been found to be capable of binding and targeting certain TA proteins to the ER 
membrane in a post-translational manner. Sec61β and Syb2 can both be cross-linked to 
SRP54, and SRP and GTP both increase insertion of Syb2 and Sec61β into microsomes 
(Abell et al., 2004). Other studies show that the cytosolic chaperones Hsc70/Hsp40 can 
interact with Sec61β, and together Hsc70 and Hsp40 enable membrane insertion of 
Sec61β and other TA proteins in a reconstituted system in the same manner as complete 
cytosol (Abell et al., 2007; Rabu et al., 2008). On the other hand these studies show that 
only very few TA proteins depend on Hsc70/Hsp40 in their targeting, but are mainly 
dependent on a different ATP-dependent factor (Rabu et al., 2008). This factor was 
identified to be the cytosolic ATPase TRC40 (Transmembrane Recognition Complex 
subunit of 40 kDa), previously known as Asna1 (arsenical pump-driving ATPase protein) 
(Stefanovic and Hegde, 2007). TRC40 is part of a by now fairly well characterised 
pathway that mediates posttranslational TA protein insertion into the ER membrane.  
 
1.4 The GET pathway 
The main components of the GET pathway are both identified in yeast and mammalian 
cells. Several factors, both cytosolic and membrane-bound, interact to enable a correct 
targeting of TA proteins into the ER membrane. 
After TRC40 had been identified as the chaperone binding the TMD of TA proteins in the 
mammalian system (Stefanovic and Hegde, 2007), the pathway was extensively studied 
in yeast, and many structural studies provided insight into the suggested molecular 
mechanisms of the pathway. 
 
1.4.1 The GET pathway in yeast 
The yeast homologue of TRC40, Get3, was shown to be involved in targeting and 
insertion of TA proteins in yeast, together with the two membrane proteins Get1 and Get2 
(Schuldiner et al., 2008). These three proteins had previously been observed to interact in 
a genetic interaction screen and were thought to play a role in the Golgi-to-ER traffic, 
resulting in the GET nomenclature (Schuldiner et al., 2005). After it became clear that 
their main role was in TA protein targeting and insertion, GET was redefined to Guided 
Entry of Tail-Anchored proteins. In this newly discovered pathway, Get3 interacts with the 
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TMD of TA proteins and targets them to the ER membrane, where Get1/Get2 form a 
heterodimeric receptor for the Get3-TA-protein-complex (Schuldiner et al., 2008). Deletion 
of the receptor leads to cytosolic accumulation and aggregation of TA proteins in complex 
with Get3, and simultaneous overexpression of some substrates leads to mislocalisation 
of these TA proteins to mitochondria (Schuldiner et al., 2008). In subsequent studies, 
three additional factors were identified to participate in the GET pathway in yeast: Get4, 
Get5 and Sgt2 (small glutamine-rich tetratricopeptide repeat-containing protein 2), which 
together form the so-called pretargeting complex (Copic et al., 2009; Jonikas et al., 2009; 
Liou et al., 2007). Get4 and Get5 were first identified in studies regarding protein folding at 
the ER and retrieval of escaped ER resident proteins, and both proteins could be shown 
to interact with Get3. Moreover, their deletion also leads to defects in TA protein targeting 
(Jonikas et al., 2009). Sgt2 on the other hand was shown to interact with Get4 and Get5 in 
a tight complex (Chang et al., 2010). 
For all the main components of the GET pathway, structural and functional analyses 
allowed a deeper insight into the molecular mechanisms behind targeting and insertion of 
TA proteins into the ER membrane (reviewed in Denic et al., 2013), as shown simplified in 
Figure 1. 
Accordingly, initial capturing of the TA protein after translation is realised by Sgt2 via its 
carboxy-terminal domain. This domain is able to discriminate between TA proteins with 
the ER as their destined target and TA proteins with the mitochondria as their destined 
target (Wang et al., 2010). Sgt2 presents the first step in a cascade that ends with the 
handing over of the TA protein substrate to Get3. The N-terminal domain of Sgt2 enables 
it to form a homodimer and interact with the ubiquitin-like domain of Get5 (Chang et al., 
2010; Chartron et al., 2011; Liou and Wang, 2005; Simon et al., 2013). Get5 itself can 
also dimerise via its carboxy-terminal (Chartron et al., 2012b), and Get4 and Get5 form a 
heterotetramer consisting of two copies of each protein. This interaction is promoted by 
the binding of Get4 to the N-terminus of Get5 (Chartron et al., 2010). Get4 also facilitates 
contact of the pretargeting complex with Get3, which binds to a conserved surface in Get4 
(Chartron et al., 2010). Binding of Get3 to Get4 locally increases the concentration of Get3 
close to the pretargeting complex and allows the transfer of the TA protein to Get3 (Wang 
et al., 2010). 
Get3 forms a homodimer, with a zinc ion being coordinated between the two monomers 
by Cysteine residues. Besides a nucleotide binding domain, each monomer owns another 
α-helical subdomain. These subdomains provide the binding groove for the TA proteins, 
as suggested by several studies. They are rich in methionine and hydrophobic residues, 
resembling the properties of the M-domain of SRP54, which is the part of SRP binding to 




Figure 1: The GET pathway in yeast. 
After release from the ribosome, a TA protein substrate is bound by the pretargeting complex consisting of 
Get4, Get5 and Sgt2, which hands it over to Get3 (1). After the complex of Get3 and the TA protein is tethered 
to the ER membrane by Get2 (2), it docks to the membrane (3). TA protein and release follows (4) before 
Get3 dissociates from the ER membrane and can be loaded with another substrate (5). 
Adopted from Denic et al., 2013 
 
Furthermore, Deuterium exchange experiments suggested a protection of this area in a 
TA protein bound state (Bozkurt et al., 2009).  
Get3 cycles between different conformations as well as between the ER and the cytosol, 
and this correlates with different nucleotide states. Upon ATP binding, the dimer is 
suggested to go into a closed state, which is then transferred to a fully closed state upon 
ATP hydrolysis, allowing the final formation of the binding groove (Bozkurt et al., 2009; 
Mateja et al., 2009; Suloway et al., 2009). In this conformation, Get3 is in a TA protein 
binding competent state, and can then cycle to the ER membrane in a Get3-TA-protein-
complex. At the ER membrane, this complex first interacts with Get 2, which is able to 
bind Get3 in its closed conformation (Mariappan et al., 2011; Stefer et al., 2011). This 
binding occurs via the cytoplasmic N-terminus of Get2 and a negatively charged surface 
patch of Get3 (Stefer et al., 2011). Current hypotheses suggest that after the Get3-TA-
protein-complex has been tethered to the ER membrane by Get2, Get1 binding to Get3 is 
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responsible for the TA protein release from Get3. Get1 can interact with Get3 also in its 
open conformation, and interaction sites include parts of the TA protein binding region as 
well as the same region that is previously bound by Get2 (Mariappan et al., 2011; Stefer 
et al., 2011). One suggested role for Get1 in this process is that it functions similar to a 
nucleotide exchange factor and can induce or maintain the open conformation of Get3 by 
interfering with nucleotide binding (Stefer et al., 2011). The open conformation of Get3 is 
associated with nucleotide release as well as TA protein release. After returning to the 
open conformation, Get3 can bind ATP again, regain its closed conformation and bind to 
another new TA protein substrate. 
In the final step, the TA protein is inserted into the ER membrane. For a long time it was 
unclear how the TMD of TA proteins is integrated into the membrane. Since in vitro some 
TA proteins were shown to insert unassisted into lipid bilayers, one discussed possibility 
was that proximity to the ER membrane is sufficient to allow unassisted insertion 
(Brambillasca et al., 2005). However, recent studies have shown that the Get1/Get2 
complex acts as an insertase for TA proteins (Wang et al., 2014). In this process, the 
cytosolic domains of Get1/Get2 cooperate with the transmembrane segments of Get1/2 to 
allow a successful release of the TA protein TMD from Get3. The TMD is then handed 
over to the transmembrane segments of Get1/Get2. This mechanism might suggest a 
general possibility of how TA proteins are inserted if they are not able to cross the 
membrane in an unassisted manner. 
 
1.4.2 The mammalian GET pathway 
In recent years, the main components of the pathway were identified in the mammalian 
system as well. An overview of the components is shown in Figure 2. After TRC40 had 
been identified early (Stefanovic and Hegde, 2007), the receptor was characterised only 
later. Similar to the situation in yeast, the receptor in the mammalian pathway is a 
heterodimer comprised of WRB and CAML (Vilardi et al., 2011; Yamamoto and Sakisaka, 
2012). WRB (tryptophan-rich basic protein) was suggested as a potential mammalian 
receptor for TRC40 based on sequence similarity to Get1. It could subsequently be shown 
to be an ER resident protein that can bind to TRC40 via its cytosolic coiled-coil domain, 
and this domain alone can act as a suppressor for TA protein insertion in vitro, showing 
that WRB acts as the receptor for TRC40 at the ER membrane (Vilardi et al., 2011). 
CAML (calcium-modulating cyclophilin ligand) has been identified in pull-down assays via 
its interaction with TRC40, and has been shown to interact with WRB as well. Similarly to 
the cytosolic domain of WRB, recombinantly expressed CAML could also suppress the 
insertion of TA proteins in vitro (Yamamoto and Sakisaka, 2012). Interestingly, also the 




Figure 2: The mammalian GET pathway. 
After the TA protein substrate (blue) emerges from the ribosome (grey), it is captures by the pretargeting 
complex consisting of TRC35, Ubl4a, SGTA and Bag6. It is then transferred to TRC40, which targets it to the 
ER membrane. There, the complex of TRC40 and the TA protein binds to the dimeric receptor comprised of 
WRB and CAML. The TA protein is inserted into the ER membrane and TRC40 is released. 
 
Overexpression of one or the other inhibits insertion of TA proteins in cells (Yamamoto 
and Sakisaka, 2012). Complementary studies in yeast with recombinantly expressed 
WRB and CAML showed that both together are necessary and sufficient to mediate TA 
protein targeting to the ER membrane (Vilardi et al., 2014). 
 
As in yeast, the TA protein in the mammalian system is captured by a pretargeting 
complex after its release from the ribosome, which is composed of Bag6 (also termed 
Bat3), TRC35 and Ubl4a (Leznicki et al., 2010; Mariappan et al., 2010). TRC35 and Ubl4a 
are the homologues of Get4 and Get5, respectively (Hu et al., 2006; Simpson et al., 
2010), but for Bag6, no equivalent yeast component is known. However, the mammalian 
homologue of yeast Sgt2, SGTA, is also associated with the mammalian pretargeting 
complex (Chartron et al., 2012a; Simon et al., 2013; Xu et al., 2012) and is suggested to 
play a role in TA protein targeting as well (Leznicki et al., 2010). 
Bag6 is also involved in several protein quality control mechanisms in the cell, being 
required in the process of ubiquitin dependent degradation of irregular proteins after 
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release from the ribosome, in ER associated degradation (ERAD) of certain membrane 
proteins, and the ubiquitination and degradation of mislocalized membrane and secretory 
proteins (Ernst et al., 2011; Hessa et al., 2011; Minami et al., 2010; Wang et al., 2011). 
Interestingly, SGTA was found to promote substrate loading to Bag6 during ERAD to 
prevent aggregation of ERAD substrate (Xu et al., 2012). On the other hand, SGTA 
counteracts the role of Bag6 in ubiquitination of mislocalised membrane proteins by 
enhancing deubiquitination of these substrates (Leznicki and High, 2012). All of these 
findings support a role of the full mammalian pre-targeting complex in protein quality 
control as well. One current hypothesis is that Bag6 can recruit different effectors via its N-
terminal Ubl-domain, with SGTA being one of these effectors and helping to prevent 
degradation of mislocalised proteins and support their correct targeting. SGTA is also 
thought to bind to either Bag6 or Ubl4a, and can also bind to TA proteins (Leznicki et al., 
2010; 2013; 2011), supporting a possible role of SGTA in targeting of TA proteins and 
keeping them in a targeting competent state. However, the full mechanism of how Bag6, 
TRC35, Ubl4a and SGTA work together is not yet fully understood. 
 
1.4.3 The GET pathway in development and cellular physiology 
While in both yeast and in the mammalian system the main components are known, there 
are still quite a few unanswered questions regarding the pathway. In yeast, the GET 
pathway is known to be non-essential under normal growth conditions, but deletion of its 
components makes yeast more susceptible to certain stress conditions such as oxidative 
or temperature stress (Metz et al., 2006; Schuldiner et al., 2008; Shen et al., 2003). In 
higher eukaryotes on the other hand knockout of the individual components has severe 
consequences. Knockout of TRC40 or CAML both results in embryonic lethality in mice 
(Mukhopadhyay et al., 2006; Tran et al., 2003). WRB is also known as CHD5 (congenital 
heart disease 5) since it was mapped to the region on Chromosome 21 that is connected 
to congenital heart diseases in trisomy 21 patients (21q22.3) (Egeo et al., 1998), and its 
disruption in Medaka fish leads to severe cardiac disorders during development (Murata et 
al., 2009). Results from our lab also suggest a role for WRB in cardiac development in 
mice and also suggest a general WRB knockout in mice to be embryonic lethal 
(unpublished). A knockout of WRB in the inner ear leads to reduced levels of the TA 
protein Otoferlin and causes impairment of the synaptic structure and function in the inner 
ear (Vogl et al., 2016). 
CAML was previously mainly known for its role in signalling and in the development and 
regulation of the immune system (Bram and Crabtree, 1994; Edgar et al., 2010; Tran et 
al., 2003). For Get3 recently a second function as an ATP-independent holdase 
chaperone under oxidative stress conditions has been found (Powis et al., 2013; Voth et 
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al., 2014). The different functions of the pathway components show that the mammalian 
GET pathway might be system far more complex than just a targeting pathway for TA 
proteins. Also so far the versatile phenotypes in yeast and higher eukaryotes upon 
deletion of parts of the pathway are mechanistically not fully understood. In yeast, the 
different phenotypes can partially be accounted for by reduced insertion of TA proteins, 
but the observed copper sensitivity in strains lacking Get3 is a result of the loss of its 
chaperone function (Schuldiner et al., 2008; Voth et al., 2014). In the mammalian system, 
the full client spectrum of the pathway is not known and an ATP-independent chaperone 
function for TRC40 has not yet been observed. It is unclear whether certain substrates 
fully depend on the pathway or whether a certain redundancy in the insertion of TA 
proteins is always given due to the participation of other chaperones in the targeting and 
insertion (Abell et al., 2004; 2007; Rabu et al., 2008). The indispensability of TRC40, 
CAML and most likely WRB however shows that some functions of the mammalian GET 
pathway or its components are absolutely necessary for the development and viability in 
higher eukaryotes. Whether this is a result of mis- or non-targeted TA proteins or is due to 
a more complex role of the pathway in general protein quality control is yet to be 
analysed. 
 
1.5 The mouse liver as a model system for studying the mammalian 
GET pathway 
So far the mammalian GET pathway has not been studied in vivo. In this study we chose 
the mouse liver as a model organ to investigate the role of this pathway in an animal 
model. 
The tissue organisation of the liver shows a relatively homogenous cell population. 80% of 
the liver mass are made up by hepatocytes (Duncan, 2000; Kmieć, 2001), providing the 
liver parenchyma in the adult organism. The main functions of the liver are versatile and 
change during development. In the foetus, the liver is the main hematopoietic organ and 
shows a high population of hematopoietic stem cells (Mikkola and Orkin, 2006; Paul et al., 
1969). The conversion to the typical composition of the adult liver along with the typical 
function occurs perinatally (Zaret, 2000). The functions of the adult liver cover a wide 
range of processes. It has a detoxifying function and shows high levels of protein 
synthesis, for example of serum proteins. The most abundant protein in the serum, 
albumin, is produced in the liver. Additionally, hormones such as angiotensinogen are 
synthesised. Other important functions of the liver include roles in the cholesterol and lipid 
metabolism and in glycogen storage. All these processes are dependent on a functioning 
ER and/or a high degree of vesicle formation and trafficking. 
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Being of such a great importance also makes the liver prone to diseases. Different causes 
can lead to malfunction and damage of the liver. Prominent examples are inflammatory 
diseases like Hepatitis C (Wang et al., 2016), alcoholic liver disease (O'Shea et al., 2010) 
or hemochromatosis (Powell et al., 2016). Often diseases of the liver lead to the formation 
of fibrotic tissue in the damaged organ, ultimately leading to liver cirrhosis (Friedman, 
2000). In some diseases, ER stress in hepatocytes has been described with an 
impairment of normal function of the cells (Baiceanu et al., 2016).  
 
1.6 Aim of the thesis 
The components of the mammalian GET pathway are essential in higher eukaryotes, yet 
the specific reason why remains unknown. The involvement of some of the components 
such as Bag6 in other protein quality control systems of the cell, and the role of Get3, the 
yeast homologue of TRC40, as an ATP-independent chaperone raise the question 
whether the mammalian GET pathway is essential due to roles in larger context of protein 
quality control, or whether its indispensability in higher eukaryotes is solely based on its 
role in TA protein targeting. Additionally, the in vivo client (TA protein or chaperone 
clients) spectrum of the pathway is not yet fully known. 
To address these questions, the following aims were defined for this study: 
 
Firstly, using the Cre-Lox system to generate a mouse line with a hepatocyte-specific 
deletion of WRB, one subunit of the heterodimeric GET receptor, and to characterise the 
morphological, histological and physiological phenotype after WRB knockout in 
hepatocytes. The liver was chosen because of its high ER content and important role in 
protein biosynthesis and secretion. 
 
Secondly, to analyse how the WRB knockout in hepatocytes affects the main pathway 
components in their expression. 
 
Thirdly, to investigate the consequences of the WRB knockout for substrates expressed in 
hepatocytes, and potentially identify clients that strictly depend on the pathway thereby 
explaining its essentiality. 
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2.1.1 Buffers and solutions 
 
Homogenisation buffer 50 mM NaCl 
0.32 M sucrose 
20 mM HEPES pH 7.4 (NaOH) 
2 mM EDTA 
protease inhibitors (Roche) 
 
Krebs-Ringer/EGTA 120 mM NaCl 
4.8 mM KCl 
1.2 mM MgSO4 
1.2 mM KH2PO4 
24 mM NaHCO3 




120 mM NaCl 
4.8 mM KCl 
1.2 mM MgSO4 
1.2 mM KH2PO4 
24 mM NaHCO3 
15 mM HEPES 
0.4% (w/v) Collagenase 
aerate with Carbogen for 30 min, bring pH to 7.4, then 
add CaCl2 from 1 mM stock to 4 mM final 
filtrate to sterilize 
 
PBS 137 mM NaCl 
2,7 mM KCl 
8 mM Na2HPO4 
1,5 mM KH2PO4 
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4% PFA in PBS 4% (w/v) PFA powder, dissolve in water plus NaOH 
with heating 
add 1/10 volume 10x PBS, adjust pH to 7.4 with HCl 
fill up to final volume with water 
 
Percoll buffer 1.4 M NaCl 
50 mM KCl 
8 mM MgCl2 
16 mM Na2HPO4 
4 mM KH2PO4 
 
Ponceau 0.2% (w/v) Ponceau S 
3% (w/v) TCA 
3% (w/v) Sulfosalicylic acid 
 
SDS loading buffer 50 mM Tris (pH 6.8) 
1% SDS 
0.1% (w/v) Bromophenol blue 
5% Glycerol 
100 mM DTT (added freshly) 
 
SDS running buffer 25 mM Tris 
250 mM Glycine pH 8.3 
0.1% SDS 
 
Solubilisation buffer 1.5% Triton-X 100 
0.75% Sodium Deoxycholate (added freshly) 
0.1% SDS (added freshly) 
50 mM TRIS-HCl (pH 7.4) 
2.5 mM EGTA 
5 mM EDTA 
protease inhibitors 
 
Transfer buffer 250 mM Tris 
1.92 M Glycine 
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Williams E medium 1 x medium from powder (Applichem, custom made 
with 5 mM instead of 10 mM Glucose) 
26.2 mM NaHCO3 
15 mM HEPES 
0.2% BSA 
 
Williams E medium 
(cell attachment) 
Williams E Medium 
5-10% FCS 
1% Gentamycin (Applichem) 
10-7 M Dexamethasone (Sigma-Aldrich) 
10-8 M Insulin (Sigma-Aldrich) 
 
Williams E medium 
(maintaining cells) 
Williams E Medium 
1% Gentamycin 
10-7 M Dexamethasone 




2.1.2 Primers for RT-qPCR 
The following table contains all sequences of the primers used for RT-qPCR. Sequences 
are always in 5’-3’ direction. For all primers used, a primer efficiency test was performed, 
using a dilution series of 1:5 to 1:625 of cDNA for each primer. 
All primers were ordered from Sigma-Aldrich. 
 
Table 1: Primers for RT-qPCR. 
Names and sequences of all primers are listed. Sequences are always in 5’-3’ direction. For, Forward. Rev, 
reverse. 







































The following tables list antibodies used for different applications. Antibodies were used 
for Western Blot and immunofluorescence as indicated in the table. 
 
Table 2: Antibodies used in the thesis. 
All antibodies used are listed with their application and the working dilution. For commercial antibodies, 
product numbers are listed. 
Raised against Species Company Application Dilution 
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WRB rabbit Synaptic Systems WB 1:500 
WB, western blot; IF, immunofluorescence 
 
2.1.4 Animals 
All animal procedures were reviewed and approved by the Institutional Animal Care and 
Use Committees of the University Medical Center Göttingen. 
The Pwifl/fl mouse line carrying a floxed allele of WRB was a kind gift from Professor David 
Corey and was published previously (Vogl et al., 2016).  
Albumin-Cre mice (B6.Cg-Tg(Alb-cre)21Mgn/J) were purchased from the Jackson 
Laboratory. In the following, mice either lacking the Cre-recombinase or being positive for 
the transgene.Alb-Cre- and Alb-Cre+ will be referred to as Alb-Cre- or Alb-Cre+. Given 
that all animals used for this work were Pwifl/fl (or WRBf/fl), animals are only named Alb-
Cre- and Alb-Cre+ in the text for simplicity. 
For this study, mice of two different age groups were used. Mice were either 6 w old or at 
least 10 w old. A full list of all animals used for experiments including age, sex and 
genotype can be found in the Appendix (Table 6). 
 
2.2 Methods 
2.2.1 Blood withdrawal 
For analysis of different parameters, blood was taken from animals aged 6 w and at least 
12 w. For this purpose, animals were anesthetized with Isoflurane followed by injection of 
appr. 400 µL Nembutal (10 mg/mL). The body cavity was opened and blood was taken 
from the Vena cava caudalis with a small syringe. For obtaining serum for the analysis, 
the syringe was rinsed with Lithium Heparine (5U/mL in water, Sigma-Aldrich) before 
drawing blood. Samples were then centrifuged at 500 x g for 30 min to collect the serum. 
 
2.2.2 Histological analysis 
For histological analysis, single lobes or the whole liver of animals at age 6 w or at least 
10 w were dissected. Animals were anesthetized with Isoflurane followed by injection of 
appr. 400 µL Nembutal (10 mg/mL). The whole liver or individual lobes were excised and 
rinsed in PBS, followed by fixation in 4% PFA in PBS o/n. The tissue was then brought to 
the Pathology Department of the University Medical Center Göttingen, where subsequent 
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fixation and dehydration steps were carried out. Afterwards, the tissue samples were 
embedded in Paraffin for sectioning and staining. Staining on 3 µm thick sections was 
carried out by the Pathology Department under Professor Ströbel. 
 
2.2.3 Isolation of primary hepatocytes 
Buffers for perfusion were prewarmed to 37°C and aerated with Carbogen (95% O2, 5% 
CO2). 
Animals were anesthetized with Isoflurane, followed by intraperitoneal injection of 400 µL 
Nembutal (10 mg/mL). After opening the body cavity, a ligature was placed around the 
Vena cava caudalis. The liver was perfused via the Vena cava caudalis, using the Vena 
portae as outflow. The liver was first perfused with appr. 125 mL Krebs-Ringer/EGTA, 
followed by perfusion with Krebs-Ringer substituted with Collagenase/HEPES/CaCl2. Due 
to the fragility of the hepatocytes in 6 w old Alb-Cre+ animals, perfusion in 6 w old animals 
in general was restricted to 4 min. After perfusion, the liver was excised, rinsed in Williams 
E medium (referred to below as medium) and manually pulled apart with forceps to wash 
out the cells, followed by a filtering step (70 µm pore size). The cells were centrifuged 
through a Percoll gradient (GE Healthcare) to separate parenchymal cells (hepatocytes) 
from non-parenchymal cells. For this purpose, the filtered cells were resuspended in 8 mL 
medium and mixed with 2.1 mL Percoll buffer and 13.9 mL Percoll. The gradient was 
followed by a washing step and the hepatocytes were resuspended in medium (1 g of 
cells in 50 mL). The amount of cells was quantified using a counting chamber. Cells were 
then either plated or pelleted, washed with PBS and snap frozen in liquid N2, followed by 
storage at -80°C. In case of plating, cells were allowed to attach in medium with serum for 
3-4 h, then medium was changed to medium without serum. 
 
2.2.4 Transcriptome analysis 
Total RNA isolated from isolated hepatocytes of 6 w old Alb-Cre- and Alb-Cre+ animals 
was subjected to Transcriptome Analysis. The analysis was performed by the 
Transcriptome and Genome Analysis Laboratory (TAL) of the University Medical School 
Göttingen (http://biochemie.uni-goettingen.de/index.php?id=709). The final list of 
differentially expressed genes was further analysed by gene ontology (GO) term 
enrichment and functional annotation clustering using the DAVID Bioinformatics 
Resources 6.7 web-based application (https://david.ncifcrf.gov/). For this analysis, only 
GO terms for biological processes were considered (using GOterm_BP_ALL). 
Also, a heatmap was created with the 50 genes showing the highest change in expression 
level according to the FDR-corrected p-values (provided by the TAL). 
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2.2.5 Immunofluorescence 
Primary hepatocytes were plated on glass coverslips coated with collagen. Cells were 
allowed to attach, using a medium with serum, and after 3-4 h, the medium was changed 
once to remove serum. Cells were cultured o/n. 
Cells were washed with PBS. Fixation was performed with PFA or methanol (depending 
on the antibody). For PFA fixation, cells were first incubated for 20 min with 2% PFA and 
0.125 M sucrose in PBS. After washing twice with PBS, cells were incubated for another 
10 min in 1% PFA in PBS. 
For methanol fixation, cells were washed twice with PBS, and fixed with ice-cold methanol 
for 5 min, preferably at 4°C with the cells on ice. Methanol was then taken off and the cells 
were washed twice with PBS. 
After fixation, cells were permeabilised for 10 min with 0.1% Triton X-100 and 0.05% SDS 
in PBS and afterwards washed twice with PBS. Blocking was performed with 10% FCS in 
PBS. Primary antibodies were incubated in PBS supplemented with 5% FCS. Incubation 
was carried out either at RT for 1 h or at 4°C o/n. Cells were washed three times with PBS 
before incubation with appropriate secondary antibodies in 5% FCS in PBS at RT for 
30 min was performed. 
 
2.2.6 Homogenisation of livers 
Livers (fresh or frozen) were homogenised using a glass Dounce homogeniser. Each liver 
was homogenised using 1 to 1.5 mL of homogenisation buffer, depending on the size. In a 
first round, a large clearance pestle was used, on average for 10 to 15 strokes. In a 
second round, a small clearance pestle was used to improve homogenisation further. 
The protein content of the homogenate was quantified with Bradford quantification, using 
the same standard curve for all samples. 
 
2.2.7 Protein extraction 
Proteins were extracted from tissue homogenate or cells by solubilisation of the sample, 
followed by TCA precipitation. 
Equal amounts of tissue homogenate (quantified by Bradford) or equal numbers of cells 
were solubilized for 30 min on ice in solubilisation buffer. Unsolubilised material was 
pelleted by ultracentrifugation at 50.000 x g for 25 min (TLA-55 rotor, Beckmann). Proteins 
in the supernatant were precipitated on ice for 10 min using TCA precipitation (12.5% final 
concentration from a 50% (w/v) stock solution). After pelleting at full speed (appr. 
16,873 x g) for 15 min at 4°C, the precipitated proteins were washed twice with acetone 
(possible to perform the second step o/n). Residual acetone was dried off at 37°C and the 
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proteins were resuspended in 1-fold SDS loading buffer and put to shaking at 37°C for at 
least 30 min. 
 
2.2.8 SDS Polyacrylamide gel electrophoresis and Western Blot 
Proteins in SDS loading buffer were separated by discontinuous SDS PAGE and 
transferred onto Nitrocellulose membrane (Amersham Protran Premium). Blotting was 
performed in a tank blot system (Hoefer) at 60V, 0.5A or 1A (depending in the tank size) 
for 80 min. Blots were stained with Ponceau and blocking was carried out for at least 
30 min at RT with 5% milk in PBS/0.1% Tween. 
Incubation with primary antibodies was performed in blocking solution at 4°C o/n or for at 
least 2 h at RT. Incubation with secondary antibodies was performed in blocking solution 
for at least 1.5 h at RT. Blots were imaged using an Odyssey®SA imaging system with 
the corresponding secondary antibodies (IRDye LICOR). 
 
2.2.9 RT-qPCR 
To assess mRNA levels of different targets, real time quantitative PCR (RT-qPCR) was 
performed. RNA was extracted from total liver homogenate or isolated hepatocytes using 
two different methods. Either a commercial RNA extraction kit (Roche High Pure RNA 
isolation kit) was used, following manufacturer’s instructions, or an isolation method with 
TRIzol® (Ambion™/ThermoFisher Scientific) was used. For isolated hepatocytes, both 
methods were applied, for total liver homogenate, only the latter was used. For this 
purpose, hepatocytes or small pieces of liver tissue were homogenised in 500 µL TRIzol, 
followed by addition of another 500 µL of the reagent. 200 µL Chloroform were added, 
and the tube was inverted 10-15 times. After incubation at RT for 3 min, the sample was 
centrifuged at 12,000 x g, 4 °C for 15 min. The aqueous upper layer was transferred to a 
fresh tube. RNA was precipitated by adding 500 µL Isopropanol and mixing well. 
Precipitation was carried out at -20 °C for at least 30 min, preferably o/n. The RNA pellet 
was then washed two times with 1 mL ice-cold 75% ethanol, followed by centrifugation at 
12,000 x g at 4 °C for 5 min. The residual ethanol was allowed to dry off, and the pellet 
was dissolved in 20-30 µL of DEPC-treated water. 
The concentration of the isolated RNA was in all cases measured with a Nanodrop 
spectrophotometer. Equal amounts (500 ng to 2 µg, depending on the concentration of 
the RNA) were subjected to cDNA synthesis, using the SuperScript® III First-Strand 
Synthesis System (Invitrogen). Random hexamer primers were used, and manufacturer’s 
protocol was followed for all procedures. For subsequent RT-qPCR, cDNA was diluted 
1:25. For all RT-qPCRs performed, GAPDH was used as reference gene. 
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2.2.10 Statistics 
In experiments where an average of values was calculated, both the standard deviation 
and the standard error of the mean (SEM) were calculated. In graphs, the error bars 
represent the SEM. 
Statistical significance was calculated with the Excel function for the regular two-tailed 
Student’s t-Test, with a two-sample equal variance (non-paired). Significance levels were 




3.1 Mice with a hepatocyte-specific WRB knockout are viable 
The Cre-LoxP deletion system was employed to allow a cell-specific knockout of WRB in 
hepatocytes. For this purpose, a mouse line carrying a WRB allele in which the exons 2, 3 
and 4 are flanked by loxP sites was crossed with a mouse line expressing the Cre 
recombinase under the Albumin promoter, ensuring a hepatocyte-specific activity of the 
Cre-recombinase (Postic et al., 1999). Two generations after the first crossing, animals 
were obtained which had two alleles of the floxed WRB and were either Alb-Cre- or Alb-
Cre+. Up to an age of 35 weeks and older, these animals were viable and displayed no 
obvious signs of sickness or any impairment. 
The expression of the Cre recombinase under the Albumin promoter reaches completion 
at around 6 w after birth (Postic and Magnuson, 2000). Until that time point, tissue 
development is not yet complete and the liver undergoes a functional transition from its 
role in haematopoiesis during the foetal stages to the roles it has in the adult animal, 
which influences the number of hepatocytes in the organ and thereby the level of Albumin 
expression (Paul et al., 1969; Weisend et al., 2009). Animals at the age of 6 w should 
show a clear phenotype, if the knockout results in such. Most of the experiments were 
carried out with animals both at 6 w and at least 10 to 12 w old to obtain a comprehensive 
characterisation. The latter group will be referred to as older animals throughout the 
thesis, and detailed information for all the animals is listed in Table 6 in the appendix. 
 
3.2 Hepatocyte-specific WRB knockout leads to strong liver damage 
in situ 
While no effect of the knockout appeared outwardly, upon opening of the body cavity a 
strong macroscopic phenotype of the liver in situ was observed. This phenotype was 
clearly visible at the age of 6 w, and increased with age. At 6 w, livers of Alb-Cre- animals 
displayed a normal liver phenotype with a smooth glossy surface of the organ and a 
homogeneous dark red colour (Figure 3A). In comparison, livers of Alb-Cre+ animals 
appeared pale and showed an irregular surface (Figure 3B). With increasing age, the 
livers of Alb-Cre+ animals differed more strongly from the ones of control animals (Figure 
3C), with nodular structures becoming visible all over the organ (Figure 3D). The severity 
of this phenotype showed variability throughout the animals that were used in this work. 
These differences in the livers influenced how well the tissue could be processed. 
Homogenisation of livers from Alb-Cre+ animals required more mechanical force to be 
applied due to the change in tissue organization and structure (cf. section 3.4). 
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To further characterise the observed in situ phenotype, I carried out experiments to 
assess the extent of liver damage. 
 
Figure 3: Livers of Alb-Cre+ animals show a strong phenotype in situ. 
Pictures of 6 w old (A, B) or older animals (C, D) animals were taken in situ. A and C show the liver of one 
Alb-Cre- animal each, while B and D show the liver of one Alb-Cre+ animal each 
 
 
3.3 The extent of liver damage is reflected in blood parameters 
Since the mouse livers showed different levels of damage on a macroscopic level, 
analysis of blood parameters related to liver damage was performed. Serum from Alb-Cre- 
and Alb-Cre+ animals at two different age points was tested for the levels of two liver 
enzymes, Alanine transaminase (ALT) and Aspartate transaminase (AST). Both enzymes 
are common markers to assess the degree of cellular damage in the liver (McClatchey, 
2002). 
In older animals, a significant increase in both ALT and AST in the serum of Alb-Cre+ 
animals compared to Alb-Cre- animals was observed (Figure 4A), indicating liver damage 
in the Alb-Cre+ animals. This increase was more drastic in the 6 w old animals, where the 
levels of both enzymes were increased by several orders of magnitude (Figure 4B), 






Figure 4: Blood parameters of Alb-Cre+ animals at two different age points confirm a strong liver 
damage. 
Serum levels of the Aspartate Transaminase (AST) and Alanine Transaminase (ALT) were analysed in either 
older animals (A) or 6 w (B) old. For the older animals, n=7 and n=7 for Alb-Cre- and Alb-Cre+ animals, 
respectively. For the 6 w old animals, n=9 and n=7 for the Alb-Cre- and Alb-Cre+ animals, respectively. Bars 
show averages -/+ SEM 
 
 
3.4 WRB knockout in hepatocytes causes alterations in liver tissue 
Since the overall appearance of livers from Alb-Cre+ animals suggested changes in the 
tissue structure itself, livers from both Alb-Cre- and Alb-Cre+ animals were subjected to 
histological analysis. Individual lobes were embedded in paraffin after fixation and 
dehydration. The analysis was performed with both 6 w and older animals. For all 
samples, an HE staining was carried out to assess the general structure and histology of 
the liver tissue. In addition to this, a Goldner-staining was performed. This staining is 
specific with regard to connective tissue, and was performed to clarify the assumption that 
connective tissue was built up in the livers.  
The HE staining revealed clear changes in the cellular organisation and structure of the 
liver tissue of Alb-Cre+ animals in both age groups (Figure 5A, B; Figure 6A, B). In the 6 w 
old animals, the majority of cells (and nuclei) appeared smaller, especially when 
compared to the erythrocytes present, while at the same time few noticeably enlarged 




Figure 5: Liver sections of 6 w old Alb-Cre+ animals show drastic changes in the tissue structure and 
cellular organization. 
3 µm sections of livers were stained with either an HE overview staining (A, B) or a Goldner staining (C, D). A 
and C show sections of Alb-Cre- animals, whereas B and D show sections of Alb-Cre+ animals. The images 
of HE-stained tissue were taken with a 250x final magnification. The images of Goldner-stained sections are in 
a 400x final magnification. 
 
regular than in the Alb-Cre- animals. Upon Goldner-staining, the histology revealed a 
large increase of connective tissue in the liver tissue of Alb-Cre+ animals, visible as blue 
patches in the tissue parenchyma. Whereas in the Alb-Cre- animals, connective tissue 
was only found in structures physiologically occurring around blood vessels, in Alb-Cre+ 
animals the liver tissue was traversed by connective tissue (Figure 5C, D).  
Additionally, the Goldner staining showed heterogeneity in the shape of the nuclei and 
different states of chromatin condensation, which indicates that some cells are undergoing 
mitosis, while others may be undergoing apoptosis. 
In older animals, the tissue of Alb-Cre+ animals showed clear differences compared to 
that of Alb-Cre- animals, but differed from the histology in the 6 w old animals. In the HE 
staining, the livers of Alb-Cre+ animals showed patches of tissue that were structurally 




Figure 6: Livers of older Alb-Cre+ animals show a clear histological phenotype. 
3 µm sections of livers were stained with either an HE overview staining (A, B) or a Goldner staining (C, D). A 
and C show sections of Alb-Cre- animals, whereas B and D show sections of Alb-Cre+ animals. All images 
were taken with a 250x final magnification. 
 
structures. The Goldner staining of sections from the same samples revealed that these 
septa consisted of connective tissue, marked by the blue structures (Figure 6D). In the 
Alb-Cre- animals connective tissue in the sections was again only found surrounding the 
blood vessels (Figure 6C). The nuclei in the two different genotypes in older animals 
appeared less different than in liver tissue from 6 w old animals, with the nuclei in the Alb-
Cre+ animals showing more consistence in their shape and status compared to 6 w old 
animals. 
Overall, the histological analysis indicated clear liver damage including fibrosis in Alb-





3.5 Hepatocyte-specific knockout of WRB leads to differential gene 
expression in Alb-Cre+ animals 
The strong phenotype in the Alb-Cre+ animals implies drastic changes in gene expression 
to compensate for the observed the damage. To gain further insight into the causes and 
molecular consequences of this phenotype, a transcriptome analysis was carried out. The 
analysis was performed with RNA from isolated hepatocytes of 6 w old animals, with four 
Alb-Cre- and four Alb-Cre+ samples being used for the calculation. The results gave a first 
indication of differentially expressed genes. For further confirmation a validation on single-
target level needs to be performed. 
After normalisation, 3185 genes were found to be differentially expressed with a cut-off of 
log2 of the fold change ≥ 1. A gene ontology (GO) term enrichment and functional 
annotation clustering analysis with this data revealed a strong enrichment in several 
processes. Overall, 224 functional clusters were annotated with an enrichment score cut-
off of 1.5. Out of 3185 genes, 513 genes were not clustered. Table 3 shows a summary of 
the 15 most enriched clusters, including the three most enriched GO terms each based on 
the EASE score (modified Fisher Exact P-Value). Many of the functional annotation 
clusters are related to cell adhesion, proliferation, cell motility and cell 
migration/chemoattraction.  
 
Table 3 Functional Annotation Clustering of differentially expressed genes in isolated hepatocytes of 
6 w old Alb-Cre+ animals. 
2672 out of 3185 genes were subjected to functional annotation clustering with the DAVID software with an 
enrichment score cut-off of 1.5. Count gives the number of genes per GO term. P-Value = EASE score 
(modified Fisher Exact P-Value). For each cluster, the three most enriched GO terms are shown. 
 
Term Count P-Value 
Annotation Cluster 1, Enrichment Score: 18.86 
GO:0007155 cell adhesion 173 4.01E-26 
GO:0022610 biological adhesion 173 5.02E-26 
GO:0016337 cell-cell adhesion 61 1.31E-06 
Annotation Cluster 2, Enrichment Score: 14.04 
GO:0007049 cell cycle 164 4.36E-18 
GO:0022402 cell cycle process 115 1.51E-15 
GO:0000278 mitotic cell cycle 83 2.09E-15 
Annotation Cluster 3, Enrichment Score: 10.94 
GO:0032502 developmental process 521 1.31E-17 
GO:0007275 multicellular organismal development 485 2.41E-17 
GO:0048856 anatomical structure development 428 1.58E-16 
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Annotation Cluster 4, Enrichment Score: 10.38 
GO:0009611 response to wounding 104 7.06E-15 
GO:0009605 response to external stimulus 155 8.25E-13 
GO:0006950 response to stress 247 4.27E-12 
Annotation Cluster 5, Enrichment Score: 8.24 
GO:0050793 regulation of developmental process 148 5.45E-15 
GO:0051239 regulation of multicellular organismal process 186 1.13E-14 
GO:0051094 positive regulation of developmental process 66 2.42E-10 
Annotation Cluster 6, Enrichment Score: 7.84 
GO:0007010 cytoskeleton organization 95 7.28E-13 
GO:0030036 actin cytoskeleton organization 52 1.07E-08 
GO:0030029 actin filament-based process 54 1.51E-08 
Annotation Cluster 7, Enrichment Score: 7.34 
GO:0032879 regulation of localization 108 9.66E-12 
GO:0051050 positive regulation of transport 41 7.15E-07 
GO:0051049 regulation of transport 67 1.37E-05 
Annotation Cluster 8, Enrichment Score: 7.24 
GO:0006928 cell motion 97 1.79E-10 
GO:0040011 locomotion 94 1.30E-09 
GO:0016477 cell migration 65 9.12E-08 
Annotation Cluster 9, Enrichment Score: 6.48 
GO:0030334 regulation of cell migration 34 8.55E-08 
GO:0051270 regulation of cell motion 37 1.46E-07 
GO:0040012 regulation of locomotion 35 2.91E-06 
Annotation Cluster 10, Enrichment Score: 6.28 
GO:0001817 regulation of cytokine production 48 1.59E-09 
GO:0051240 positive regulation of multicellular organismal process 45 6.40E-06 
GO:0001819 positive regulation of cytokine production 23 1.45E-05 
Annotation Cluster 11, Enrichment Score: 5.98 
GO:0001944 vasculature development 69 1.55E-08 
GO:0001568 blood vessel development 67 3.18E-08 
GO:0048514 blood vessel morphogenesis 54 1.00E-06 
Annotation Cluster 12, Enrichment Score: 5.58 
GO:0040011 locomotion 94 1.30E-09 
GO:0042330 taxis 38 7.59E-08 
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GO:0006935 chemotaxis 38 7.59E-08 
Annotation Cluster 13, Enrichment Score: 4.80 
GO:0030155 regulation of cell adhesion 36 1.15E-08 
GO:0045785 positive regulation of cell adhesion 20 1.25E-06 
GO:0010810 regulation of cell-substrate adhesion 14 
0.002 
 
Annotation Cluster 14, Enrichment Score: 4.12 
GO:0030154 cell differentiation 307 2.32E-11 
GO:0007399 nervous system development 170 4.26E-07 
GO:0030030 cell projection organization 76 1.75E-06 
Annotation Cluster 15, Enrichment Score: 3.81 
GO:0001775 cell activation 72 4.59E-10 
GO:0045321 leukocyte activation 61 8.13E-08 




In addition to the broad GO term analysis, a heatmap was created showing the 50 genes 
with the highest change in expression when comparing Alb-Cre- with Alb-Cre+ animals 
(Figure 7). These included genes involved in liver fibrosis and regeneration such as 
several collagen genes or Tgfbi and Sparc (Nakken et al., 2007). The corresponding list of 
the genes is listed inTable 7 in the Appendix. 
Figure 7: Heatmap of the 50 genes showing the highest change in differential expression. 
The transcriptome of four Alb-Cre- and for Alb-Cre+ animals was analysed for differentially expressed genes. 
The heatmap shows the genes which displayed the highest change in expression according to FDR-adjusted 
p-values upon comparing the two genotypes. 
 
Furthermore, TA proteins expressed in hepatocytes were extracted from the transcriptome 
data. The list can be found in the Appendix (Table 8). Since the transcriptome analysis 
was carried out only at a late stage of this project, I was not able to follow up on the 
results regarding the differential expression of some of these TA proteins. The list has to 
be considered as preliminary data for further analysis. However, in this thesis several 
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selected TA proteins were analysed in vivo (cf. section 3.7), and all of these selected TA 
proteins appeared in the transcriptome. 
The selection of TA proteins for following experiments was based on different aspects. 
Many of selected ones have previously been used in vitro and are part of numerous 
published studies. Another aspect was whether they were highly conserved between 
yeast and mouse and were shown to be affected in yeast upon disturbance of the GET 
pathway. More detailed information regarding the selected TA proteins based on these 
two aspects can be found in section 3.7. Additionally, the availability of working antibodies 
for the selected TA proteins was crucial for the analysis. I selected only TA proteins for 
which reliable antibodies were available. But not only for TA proteins this was a 
prerequisite. The availability of antibodies for the pathway components was indispensable 
for investigating the effects of the WRB knockout on the pathway. 
In the following sections I will describe the results of further analysis of both pathway 
components and selected TA proteins. 
 
3.6 The components of the mammalian GET pathway are influenced 
by the knockout of WRB in hepatocytes 
Upon expression of the Cre recombinase under the Albumin promoter, the excision of the 
three middle exons of the floxed WRB allele took place. The consequences of this 
recombination were detectable at mRNA and steady-state protein level. Real time 
quantitative PCR (RT-qPCR) and Western Blotting were performed to assess the effects 
of a WRB knockout in isolated hepatocytes and in total liver homogenate. These 
experiments were performed in mice of two age groups, as before 6 w old and older 
animals. 
 
3.6.1 In 6 week old animals, liver tissue and isolated hepatocytes react differently 
to the knockout 
Analysis of the livers of 6 w old animals was performed with total liver homogenate as well 
as with isolated hepatocytes. Since hepatocytes make up about 80% of the adult liver 
(Duncan, 2000), and the in situ and histological analyses indicated a strong knockout 
phenotype, I expected these effects to be reflected at mRNA and steady-state protein 
level in both total liver homogenate and isolated hepatocytes. 
To test whether the excision of the three middle exons (2,3 and 4) of the floxed WRB 
allele was accomplished, primers were designed to quantify the mRNA levels of WRB via 
RT-qPCR. The forward primer is positioned at the junction of exon 3 and 4, while the 
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reverse primer anneals in exon 5. Upon recombination of the floxed allele, the forward 
primer can no longer anneal and no PCR product can be generated. 
From both total liver homogenate and isolated hepatocytes of 6 w old animals, RNA was 
extracted and after reverse transcription to cDNA, RT-qPCR was used to quantify the 
mRNA levels of the three pathway components: WRB, CAML and TRC40. In RNA 
samples from isolated hepatocytes, the WRB mRNA level in Alb-Cre+ animals was 
significantly reduced to about 50% on average, but the level of reduction varied 
considerably among individual samples (Figure 8A). This indicates that not all hepatocytes 
were WRB knockout hepatocytes. However, the mRNA level of WRB in the Alb-Cre- 
animals showed variability as well, indicating that the expression of WRB at mRNA level 
varied in hepatocytes under physiological conditions. 
In total liver homogenate of 6 w old animals, the WRB mRNA level also displayed a 
significant reduction on average (Figure 9A, D), to less than 50% compared to Alb-Cre- 
animals. Expression levels in both total liver homogenate and isolated hepatocytes were 
in a very similar range relative to GAPDH, which was used as reference gene in the 
analysis. Overall, the results of the RT-qPCR indicated that Cre recombinase mediated 
excision of exons 2 to 4 of the floxed WRB allele had an effect on the expression level of 
WRB mRNA. 
To evaluate whether downregulation of WRB had an effect on the mRNA levels of the 
other main components of the pathway, CAML and TRC40, primers were designed to 
measure the mRNA levels of these two proteins via RT-qPCR. CAML is the direct partner 
of WRB in the formation of the dimeric GET receptor in the ER membrane, while TRC40 is 
the cytosolic ATPase that targets TA proteins to the ER membrane. In hepatocytes, the 
amount of CAML mRNA showed a lot of variation regardless of the genotype of the 
animals. Overall, CAML mRNA levels of Alb-Cre+ animals did not differ significantly from 
Alb-Cre- animals, indicating that the downregulation of WRB at mRNA level had no 
influence on the mRNA level of CAML in hepatocytes (Figure 8B, D). The same trend was 
observed in the RT-qPCR results with RNA from total liver homogenate of 6 w old mice. 
The CAML mRNA level did not change as a consequence of the reduction of WRB at 
mRNA level (Figure 9B, D). The RT-qPCR results for TRC40 displayed a slight increase 
of TRC40 in isolated hepatocytes of 6 w old Alb-Cre+ animals compared to Alb-Cre- 
animals (Figure 8C, D). This increase was significant despite the strong variation in the 
expression of TRC40 in animals of both genotypes (p = 0.04). The RT-qPCRs performed 
with RNA from total liver homogenate from 6 w old Alb-Cre- and Alb-Cre+ animals 
supported these results. Here, a slight increase of the TRC40 mRNA level was observed 





Figure 8: In isolated hepatocytes of 6 w old Alb-Cre+ animals mRNA levels of WRB and TRC40 were 
significantly changed. 
RT-qPCR was performed with mRNA extracted from isolated hepatocytes of 6 w old animals. A, B and C 
show boxplots of the relative mRNA levels of WRB, CAML and TRC40. The same samples were used, with 
outliers excluded from calculating the whiskers. Relative levels are given as 2^-dCP of the target over 
GAPDH. D shows averages of Alb-Cre- and Alb-Cre+ samples -/+ SEM. Where changes were significant, p-
values are indicated over the boxplots and the level of significance is marked in D. For Alb-Cre- animals, 





Figure 9: In total liver homogenate of 6 w old Alb-Cre+ animals the mRNA level of WRB was 
significantly changed. 
RT-qPCR was performed with mRNA extracted from total liver homogenate of 6 w old animals. A, B and C 
show dot plots of the relative mRNA levels of WRB, CAML and TRC40. The same samples were used for al l 
three plots. Relative levels are given as 2^-dCP of the target over GAPDH. D shows averages of Alb-Cre- and 
Alb-Cre+ samples -/+ SEM. If changes were significant, p-values are indicated over the boxplots and the level 




Overall, I could observe a significant decrease of WRB at mRNA level in both total liver 
homogenate and isolated hepatocytes of 6 w old Alb-Cre+ animals. Except for a 
significant increase of the TRC40 mRNA level in isolated hepatocytes of Alb-Cre+ 
animals, the other two pathway components remained unchanged. 
 
Since the results of the RT-qPCR indicated a successful recombination of the floxed WRB 
allele in 6 w old Alb-Cre+ animals, the effect of this recombination on steady-state protein 
levels was analysed by performing Western Blots for the three pathway components 
WRB, CAML and TRC40. For this purpose, proteins were extracted from both total liver 
homogenate and isolated hepatocytes of 6 w old Alb-Cre- and Alb-Cre+ animals. 
In the experiments carried out with total liver homogenate, immunoblotting for WRB did 
not reveal a significant change of the WRB steady-state protein level in the Alb-Cre+ 
animals (Figure 10A, B), although a tendency towards WRB reduction was observed. The 
individual samples on the blot however indicated that the steady-state amounts of WRB at 
protein level varied considerably. Some animals displayed a strong reduction of WRB (cf. 
animals 208, 209 and 210 in Figure 10A), while the signal on the blot of other animals 
resembled the situation found in the Alb-Cre- control animals (cf. animals 240 and 241 in 
Figure 10A). These results again suggested variability in the number of hepatocytes 
lacking WRB in different Alb-Cre+ livers. Interestingly, the steady-state protein level of the
second component of the receptor, CAML, showed a significant decrease in total liver 
homogenates of Alb-Cre+ animals. CAML protein levels were on average 40% less in Alb-
Cre+ animals compared to Alb-Cre- control animals (Figure 10A, B). This result suggested 
that already small changes in the steady-state protein amount of WRB might have a 
drastic impact on the stability of the dimeric receptor in the ER membrane. 
The steady-state protein level of the central targeting component of the pathway, TRC40, 
was assessed by immunoblot as well. While the level of TRC40 mRNA showed a 
tendency towards increase in total liver homogenate of Alb-Cre+ animals, this effect was 
not noticeable at steady-state protein level. No difference at all was observed between the 
steady-state protein levels of TRC40 in total liver homogenate of Alb-Cre+ animals 
compared to Alb-Cre- animals (Figure 10A, B). 
Although the whole liver of Alb-Cre+ animals displayed a strong phenotype, it might be 
exactly this liver damage that alters the cell composition (e.g. increased amount of 
fibroblasts or infiltrating leucocytes compared to the number of hepatocytes) or 
homogenisation properties of the livers due to occurring fibrosis, and due to this the 
results might not be representative. 
For this reason, all Western Blots were repeated with isolated hepatocytes to evaluate the 
impact of WRB knockout in only the cells in which the recombination took place. Isolated
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Figure 10: In total liver homogenates of 6 w old Alb-Cre+ animals only CAML was significantly affected 
at protein level  
Protein extracts from total liver homogenates of 6 w old animals were subjected to SDS PAGE and Western 
Blotting. A shows the immunoblotting with antibodies against the pathway components WRB, CAML and 
TRC40. The asterisk marks the specific signal obtained with the TRC40 antibody. B shows the quantification 
of the signals in A. The bars represent averages -/+ SEM. For the changes in CAML p = 0.0052 (**). For Alb-
Cre- animals, n = 6, for Alb-Cre+ animals n = 6. 
 
hepatocytes from several animals of each genotype were analysed by Western regarding 
the protein levels of WRB, CAML and TRC40 in these cells. For WRB no significant 
reduction could be observed in the Alb-Cre+ animals (Figure 11A, B), but isolated 
hepatocytes showed a tendency towards reduction of WRB. Upon comparing individual 
animals on the blot, it became evident that the steady-state protein level of WRB varied 
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considerably in isolated hepatocytes. While some Alb-Cre+ animals displayed a clearly 
visible reduction of WRB, other animals of the same genotype resembled the situation of 
the Alb-Cre- control animals (cf. animals 319 and 330, Figure 11A). The steady-state 
protein level of CAML in hepatocytes of 6 w old animals decreased in the Alb-Cre+ 
animals, but unlike the blots of total liver homogenate, the change in the isolated 
hepatocytes was not significant (Figure 11A, B). However, the individual Alb-Cre+ animals 
showed strong variation in the amounts of CAML detected, correlating with the WRB 
steady-state protein level. If WRB was reduced, so was CAML. 
For TRC40, the isolated hepatocytes of Alb-Cre+ animals exhibited some increase of 
TRC40 at protein level, but while this result recapitulates the result of the RT-qPCR for 
TRC40 in hepatocytes of 6 w old Alb-Cre+ animals, the change at steady-state protein 
level was not statistically significant (Figure 11A, B). 
 
Since WRB showed that much variation at both mRNA and protein level in the Alb-Cre+ 
animals, a closer look was taken at the RT-qPCR results of WRB at mRNA level. In total, 
hepatocytes of 10 Alb-Cre- and 11 Alb-Cre+ animals were subjected to RNA extraction 
and RT-qPCR (see Figure 8). In both genotypes, the mRNA level varied greatly, 
suggesting a different amount of knockout hepatocytes in individual Alb-Cre+ animals as 
well as a physiological variability in WRB expression. Overall, there was a significant 
reduction of WRB at mRNA level down to 47% in hepatocytes of Alb-Cre+ animals, but 
the individual animals displayed a wide range from a very strong reduction to about 15% 
up to completely normal WRB mRNA level (the latter animal is depicted as an outlier in 
Figure 8). Since the mRNA level of a protein does not always correlate well with the actual 
protein level (reviewed in Liu et al., 2016), the question arose whether an average 
reduction of WRB mRNA down to about 50% is enough to see an effect at protein level. 
To address this further, immunoblotting for the pathway components was performed with 
Alb-Cre+ animals showing different grades of WRB reduction at mRNA level. Two Alb-
Cre+ animals with a very low WRB mRNA level (25th percentile of the boxplot in Figure 8) 
and two Alb-Cre+ animals with an intermediate WRB mRNA level (50th percentile of the 
boxplot in Figure 8) were analysed, along with two control Alb-Cre- animals. The results of 
this experiment displayed a clear correlation between WRB at mRNA level and WRB at 
steady-state protein level, but not in a linear fashion (Figure 12A). Only if a strong 
reduction of the WRB mRNA level was seen, was the protein level strongly decreased 
(animals 292 and 290 in Figure 12A). If the mRNA reduction was moderate, no decrease 
of WRB at steady-state protein level was observed (animals 337 and 315 in Figure 12A). 
The same effect was visible for the steady-state protein level of CAML – if a strong 
reduction of WRB mRNA level, i.e. a high number if knockout hepatocytes, was present,
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Figure 11: In isolated hepatocytes of 6 w old Alb-Cre+ animals, no significant change of the protein 
levels of the pathway components was observed. 
Protein extracts from isolated hepatocytes of 6 w old animals were subjected to SDS PAGE and Western 
Blotting. A shows the immunoblotting with antibodies against the pathway components WRB, CAML and 
TRC40. The asterisk marks the specific signal obtained with the TRC40 antibody. B shows the quantification 
of the signals in A. The bars represent averages -/+ SEM. N = 5 for both Alb-Cre- and Alb-Cre+ animals. 
 
CAML strongly decreased at protein level (Figure 12B, animals 292 and 290). A moderate 
reduction of WRB at mRNA level led to only a slight or no reduction of CAML at protein 
level (Figure 12B, animals 337 and 315). 
For TRC40 however, yet another effect was observed: In Alb-Cre+ animals that showed a 
strong reduction of WRB mRNA, the TRC40 steady-state protein level decreased a little 




Figure 12: Variability in the knockout strength of WRB at mRNA level correlated with changes at 
protein level of the pathway components in Alb-Cre+ animals. 
Western Blots for the three pathway components were performed with animals showing different knockout 
grades of WRB at mRNA level (A, WRB; B, CAML; C, TRC40). The strength of the knockout is given under 
the blots. ++ represents animals from the 25th percentile, + animals from the 50th percentile in Figure 8. Bars 
always show the quantification of the protein relative to the Na/K-ATPase. 
 
led to either no change or a slight increase of the TRC40 steady-state protein level 
(animals 337 and 315 in Figure 12C). 
 
Taken together, these results indicate that the variability of the knockout degree at mRNA 
level accounts for the non-significant changes in WRB steady-state protein levels in both 
isolated hepatocytes and total liver homogenate. The results suggest that the livers of all 
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animals contained mixtures of knockout hepatocytes and hepatocytes that escaped 
recombination. In the mosaic tissue or isolated hepatocytes, the reduction of WRB at 
mRNA level had to be somewhere below a certain threshold (between 20% and 40% 
WRB mRNA left) before a clear effect at the steady-state protein level was visible. Since 
only about 20% of the animals analysed did show such a strong reduction of WRB at 
mRNA level, the average reduction of WRB and CAML steady-state protein levels was not 
always visible despite the significant average reduction of WRB mRNA level in 6 w old 
Alb-Cre+ animals. 
However, when a substantial reduction of the WRB mRNA level was present, this affected 
steady-state protein levels of WRB and CAML. For a further characterisation, the analysis 
of the pathway components was carried out in older animals. 
 
3.6.2 In older animals, the hepatocyte-specific WRB knockout affects liver tissue 
and isolated hepatocytes in different ways 
Since the in situ phenotype appeared more severe with increasing age, both total liver 
homogenate and isolated hepatocytes of older Alb-Cre- and Alb-Cre+ animals were 
subjected to the same experiments as the samples from 6 w old animals. The expression 
of the main pathway components WRB, CAML and TRC40 was determined at mRNA and 
protein level. 
In a first screen, I tested whether a successful excision of the middle exons of the floxed 
WRB allele could be observed in older Alb-Cre+ animals as well and whether this affected 
the mRNA levels of the other two main components of the pathway, CAML and TRC40. 
RNA was extracted from both total liver homogenate and isolated hepatocytes, and RT-
qPCR was performed. In total liver homogenate from older animals, no apparent change 
of WRB at mRNA level was observed (Figure 13A, D). While the variation in the Alb-Cre- 
control animals was comparably small, the Alb-Cre+ animals again displayed a large 
variability, resulting in no change in the WRB mRNA level on average. Interestingly, the 
mRNA level of CAML, the partner of WRB in the ER membrane, was significantly 
increased in Alb-Cre+ animals (Figure 13B, D), which was not the case in the 6 w old 
animals, independent of the sample type (total liver homogenate or isolated hepatocytes). 
The mRNA level of the cytosolic component, TRC40, showed a tendency for increase in 
Alb-Cre+ animals (Figure 13C, D), which had been observed in total liver homogenate 
and isolated hepatocytes of 6 w old Alb-Cre+ animals as well. In total liver homogenate of 
older animals, this increase was not significant. 
As already mentioned in 3.5.1, it is possible that the loss of WRB leads to massive 
damage and therefore changes in cellular composition of the liver, resulting in relatively 
fewer hepatocytes contributing to the total liver mass.  
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Figure 13: In older Alb-Cre+ animals, WRB and TRC40 remained unchanged at mRNA level, while 
CAML increased in total liver homogenate. 
mRNA isolated from total liver homogenate of older animals was used to analyse mRNA levels of the pathway 
components by RT-qPCR. A-C show boxplots of the individual samples, with the 2^-dCP values of the target 
over GAPDH given on the y-axis. D shows the averages -/+ SEM of A-C. The p-value for the significant 
change in CAML mRNA levels is given above the boxplot in B and is also represented in the graph in D. For 
both Alb-Cre- and Alb-Cre+ animals, n = 5. 
 
To investigate the effect of WRB knockout exclusively in the cell type in which the 
recombination occurred, mRNA levels of the pathway components were quantified by RT-
qPCR with RNA extracted from isolated hepatocytes. 
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RT-qPCR with RNA from isolated hepatocytes led to different results than previously 
observed with RNA from total liver homogenate. When analysing mRNA from isolated 
hepatocytes, the mRNA level of WRB in Alb-Cre+ animals showed a highly significant 
decrease compared to Alb-Cre- animals (Figure 14A, D). The level of WRB mRNA was on 
average decreased to about 50%, which resembled the results observed in isolated 
hepatocytes from 6 w old animals. Although isolated hepatocytes from only four older 
animals could be subjected to RT-qPCR, a large variation in the WRB mRNA level can be 
observed (Figure 14A). Regarding the mRNA level of CAML, no difference was detected 
when comparing Alb-Cre+ animals to Alb-Cre- control animals (Figure 14B, D). Similar 
results were seen for TRC40, where the mRNA level in the Alb-Cre+ animals did not differ 
significantly from the mRNA level in Alb-Cre- animals (Figure 14C, D). 
Overall, the results from the RT-qPCR experiments in older animals showed that in total 
liver homogenate no significant reduction of WRB at mRNA level occurred, but when 
analysing isolated hepatocytes, a significant decrease of WRB at mRNA level was 
observed.  
Experiments were performed to evaluate how the knockout of WRB translates to WRB 
steady-state protein amounts in older animals. Proteins were extracted from total liver 
homogenate and isolated hepatocytes from older animals and immunoblotting for WRB, 
CAML and TRC40 was carried out. The livers of older animals showed a strong 
phenotype in situ, so it was assumed that effects of the WRB knockout at protein level 
should be visible with samples prepared from total liver homogenate. 
As for WRB, the immunoblotting with total liver homogenate did not reveal any change in 
the WRB steady-state protein level when comparing Alb-Cre+ with Alb-Cre- animals 
(Figure 15). Although individual samples displayed a visible decrease on the blot (animals 
175, 176 in Figure 15), the reduction was not significant overall. 
CAML did not show a significant change between Alb-Cre+ and Alb-Cre- animals at 
steady-state protein level in total liver homogenate of older animals (Figure 15), although 
the mRNA level in total liver homogenate was significantly increased. On the other hand, 
while showing no significant change at mRNA level, the steady-state protein level of 
TRC40 was significantly increased in Alb-Cre+ animals compared to the control animals 
(p-value = 0.04, Figure 15). These results indicate that changes at mRNA and steady-
state protein levels did not necessarily correlate and need further analysis and discussion. 
To compare the results from total liver homogenate to isolated hepatocytes of older 
animals, the blots were repeated with isolated hepatocytes. In the blots, one Alb-Cre+ 
animal was included that did not show any phenotype in situ. It was not included in the 
quantification, but again supported the finding of the large variability in the WRB knockout 
in hepatocytes. This sample is marked by an arrowhead in Figure 16. 
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Figure 14: Isolated hepatocytes of older Alb-Cre+ animals showed a significant reduction of WRB at 
mRNA level. 
mRNA of isolated hepatocytes from ≥ 11 w old animals was subjected to RT-qPCR to analyse mRNA levels of 
the pathway components. A to C show dot plots of the individual animals. Relative levels are given as 2^-dCP 
of the target over GAPDH. D shows averages -/+ SEM of the plots in A to C. The significance level of the 
change in WRB mRNA levels is indicated in A and D. For both Alb-Cre- and Alb-Cre+ animals, n = 4. 
 
When probing for WRB, isolated hepatocytes from Alb-Cre+ animals showed a significant 
decrease of WRB at steady-state protein level down to about 60% (Figure 16). 
Interestingly, the one animal that was not included in the quantification showed a higher 
protein level on the Western Blot, indicating a correlation between the absence of 
phenotype in situ and the amount of WRB protein in hepatocytes. Also for CAML, a
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Figure 15: In total liver homogenate from older animals, only TRC40 showed a significant change in 
Alb-Cre+ animals. 
Protein extracts from total liver homogenate of older animals were analysed by Western Blotting. A shows the 
immunoblotting for WRB, CAML and TRC40. The asterisk marks the specific signal obtained with the TRC40 
antibody. B shows the quantification of A, given as averages -/+ SEM. The significance in the change of 
TRC40 is indicated in B (p-value = 0.04). For Alb-Cre- animals, n = 5, for Alb-Cre+ animals, n = 5. The blot 
always shows only four individuals in each group. Animal numbers are indicated. 
 
significantly decreased steady-state protein level in Alb-Cre+ animals was observed 
(Figure 16), while again the animal lacking the typical in situ phenotype displayed a much 
higher signal of CAML on the Western Blot. Additionally, the other Alb-Cre+ animals, 
which had shown a clear phenotype in situ, varied in the extent of the reduction of WRB 
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and CAML, indicating the high variability of the knockout penetrance in hepatocytes. In 
contrast to WRB and CAML, TRC40 did not show any change at steady-state protein level 
in the Alb-Cre+ animals compared to Alb-Cre- animals (Figure 16). 
 
Figure 16: In isolated hepatocytes of older Alb-Cre+ animals, WRB and CAML were significantly 
reduced at protein level. 
Protein extracts from isolated hepatocytes of older animals were analysed by Western Blotting. A shows the 
immunoblotting for WRB, CAML and TRC40. The asterisk marks the specific signal obtained with the TRC40 
antibody. B shows the quantification of A, given as averages -/+ SEM. The significance in the change of WRB 
and CAML are indicated in A and B. For WRB, p-value = 0.008. For CAML, p-value = 0.001. The signal from 
the Alb-Cre+ animal marked with the arrowhead was not included in the quantification. For Alb-Cre- animals, 




Taken together, I showed that in older animals the WRB knockout was visible only in 
isolated hepatocytes, while samples from total liver homogenate did not display a 
significant reduction of WRB at mRNA or steady-state protein level, despite the strong 
phenotype of the liver in situ. As previously shown for 6 w old animals, in older animals a 
large variability in the penetrance of the knockout was observed. 
 
Overall, I could show that the decrease of WRB at mRNA level had to go below a certain 
threshold to lead to a reduction of WRB at steady-state protein level. Furthermore, a 
strong decrease of WRB at steady-state protein-level caused a reduction of CAML at 
steady-state protein level. The following table provides a summary of the results obtained 
for the pathway components at mRNA and protein level in the different age groups. 
 
Table 4: Summary of the section 3.6. 
The levels of mRNA or steady-state protein for the pathway components is shown. á refers to a significant 
increase, â  to a significant decrease and — to no significant change. Cells, isolated hepatocytes. Hmg, total 
liver homogenate.  
 mRNA protein 
WRB CAML TRC40 WRB CAML TRC40 
6 w 
cells â — á — — — 
hmg â — — — â — 
older 
animals 
cells â — — â â — 
hmg — á — — — á 
 
Since a WRB knockout in hepatocytes led to a decrease in steady-state protein levels of 
WRB and CAML, the effect of this reduction on selected TA proteins expressed in 
hepatocytes was analysed. Investigating the consequences of the WRB knockout for 
substrates of the GET pathway might help to understand the in vivo client spectrum. The 




3.7 A hepatocyte-specific WRB knockout has varying effects on 
selected substrates of the mammalian GET pathway  
One of the still largely unknown aspects of the mammalian GET pathway is the in vivo 
client spectrum, and whether a dependence of some substrates on the pathway is a 
possible reason for its essential nature in higher eukaryotes. To gain further insight into 
the behaviour of substrates of the pathway, I analysed total liver homogenate and isolated 
hepatocytes of 6 w old and older animals regarding selected substrates. The selected TA 
proteins were the three SNAREs Syntaxin 5 (Stx5), Syntaxin 6 (Stx6) and Syntaxin 8 
(Stx8), Emerin (EMD), and the translocon subunit Sec61β. These were all expressed in 
hepatocytes, as was shown in the transcriptome analysis (cf. Table 8). Furthermore, they 
have been shown in our lab to be substrates of the mammalian GET pathway in vitro or 
have been published to be substrates of the mammalian GET pathway (Abell et al., 2007; 
Pfaff et al., 2016; Stefanovic and Hegde, 2007). In the case of Stx5, its yeast homologue 
Sed5 is affected by deletion of GET pathway components in yeast (Schuldiner et al., 
2008). 
The following chapters describe the results I obtained when investigating these TA 
proteins in Alb-Cre+ animals. 
 
3.7.1 In 6 week old animals, selected substrates behave differently in liver tissue 
and isolated hepatocytes of Alb-Cre+ animals 
As already described for the pathway components in samples from 6 w old animals, 
Western Blot analysis was performed for the substrates with both total liver homogenate 
samples and isolated hepatocytes. The same samples as for analysis of the pathway 
components were used. 
When total liver homogenate was used for Western Blots, two of the four substrates that 
were analysed showed a significant change at steady-state protein level in Alb-Cre+ 
animals (Figure 17A, B). Syntaxin 5 (Stx5), a t-SNARE with two different isoforms found in 
the ER (42 kDa) and the Golgi apparatus (35 kDa) (Hay et al., 1998; Hui et al., 1997), 
displayed a highly significant decrease down to about 40% in Alb-Cre+ animals compared 
to Alb-Cre- animals, while Emerin (EMD), a TA protein of the inner nuclear membrane 
(Manilal et al., 1998), was significantly increased by about 40% in Alb-Cre+ animals 
compared to Alb-Cre- animals (Figure 17). In the case of Stx5, both isoforms were 
detected with the antibody used, and both isoforms (both appearing in a double band 
each) showed a similar behaviour upon quantification (Figure 17A, B). The other two 





Figure 17: In total liver homogenate of 6 w old Alb-Cre+ animals Stx5 and EMD showed a significant 
change. 
Protein extracts from total liver homogenate of 6 w old animals were subjected to SDS PAGE and Western 
Blot to analyse the protein level of different substrates of the mammalian GET pathway. Immunoblotting is 
shown in A. The quantification of the signals in A is shown in B, bars show averages -/+ SEM. For both Alb-
Cre- and Alb-Cre+ animals, n = 6. Significance levels of significant changes are indicated in B (for Stx5, p-





Syntaxin 8 (Stx8), did not show significant differences at steady-state protein level in total 
liver homogenates of Alb-Cre+ animals compared to Alb-Cre- animals, although Stx8 
indicated a tendency to be increased in Alb-Cre+ animals compared to Alb-Cre- animals 
(Figure 17B). 
 
As described in earlier chapters, the quantification of different substrates in total liver 
homogenates might be influenced by a putative change of the cellular composition of the 
liver and different homogenisation properties. For this reason, the Western Blot as well as 
an RT-qPCR analysis was performed to evaluate the steady-state levels of selected 
substrates in isolated hepatocytes. 
In isolated hepatocytes, all substrates already probed for in total liver homogenate were 
tested. Additionally, immunoblotting was performed for Sec61β, a TA protein that is part of 
the Sec61 translocon in the ER membrane and has previously been characterised as a 
substrate of the mammalian GET pathway (Abell et al., 2007; Stefanovic and Hegde, 
2007). In contrast to the Western Blots carried out with total liver homogenate, the 
substrates displayed a different behaviour in isolated hepatocytes. All of the substrates 
tested (Stx5, Stx6 Stx8, EMD and Sec61β), were successfully detected (Figure 18A), but 
only Stx6 changed at steady-state protein level and was significantly reduced to about 
56% in Alb-Cre+ animals (Figure 18B). All other substrates did not show any significant 
change at steady-state protein level. Sec61β was the only substrate that showed a 
tendency to be decreased, but not significantly.  
To analyse these results further, RT-qPCR was performed for all the substrates that had 
been previously evaluated by Western Blot. The results of the RT-qPCR revealed that the 
decrease of Stx6 at protein level correlated with a reduction of Stx6 at mRNA level in 
hepatocytes of Alb-Cre+ animals compared to Alb-Cre- animals (Figure 19B, F). The 
reduction of the Stx6 mRNA level down to about 76% was significant (p-value = 0.014). All 
the other substrates tested did not show any significant change at mRNA level, but most 
of them showed quite some variability from sample to sample (Figure 19A-E). 
Immunoblotting and RT-qPCR analysis of the 6 w old animals had not shown significantly 
reduced WRB protein and mRNA steady-state levels (see 3.6.1). Still, some of the 
substrates reacted to the knockout of WRB despite the mild penetrance. To evaluate how 
the selected substrates react to a strong reduction of WRB mRNA and protein level, as 
previously samples with a strong and an intermediate WRB knockout penetrance were 
used to perform Western Blots and analyse the correlation between WRB reduction and 
effect on the substrates (cf. Figure 12). Due to very low amounts of material available, 




Figure 18: In isolated hepatocytes of 6 w old Alb-Cre+ animals only steady-state protein levels of Stx6 
displayed a significant change  
Protein extracts from isolated hepatocytes of 6 w old animals were subjected to SDS PAGE and Western Blot 
to analyse the steady-state protein levels of different substrates of the mammalian GET pathway. 
Immunoblotting is shown in A. The quantification of the signals in A is shown in B, bars show averages -/+ 
SEM. For both Alb-Cre- and Alb-Cre+ animals, n = 5. Significance levels of significant changes are indicated 
in B (forStx6, p-value = 0.002). 
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Figure 19: In isolated hepatocytes of 6 w old Alb-Cre+ animals Stx6 was significantly reduced at 
mRNA level. 
mRNA obtained from isolated hepatocytes of 6 w old animals was subjected to RT-qPCR to evaluate the 
mRNA levels of substrates of the mammalian GET pathway. A to E show boxplots of the relative mRNA level 
(plotted as 2^-dCP values of the targets over GAPDH) of different substrates. Outliers are not included in the 
whiskers. F shows the quantification of the boxplots as averages -/+ SEM. The significance level for the 
change of Stx 6 is indicated in both B and F. For Alb-Cre-, n = 10. For Alb-Cre+, n = 11. 
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to analyse the consequences of WRB knockout in different tissues have shown that Stx5 
is strongly affected in WRB knockout cardiac myocytes (experiments performed by Jhon 
Rivera-Monroy and described here for the purpose of discussion). On the other hand Stx8 
was not affected in this other mouse model and displayed no significant changes in 
isolated hepatocytes or total liver homogenate. 
The Western Blots revealed that Stx5 reacted to a WRB knockout and was reduced at 
steady-state protein level if a strong penetrance of the WRB knockout was present (Figure 
20, animals 292 and 290). A moderate reduction of the WRB mRNA level however did not 
lead to a large change of Stx5 at steady-state protein level (Figure 20A, animals 337 and 
315). This suggests that due to a lack of a strong WRB reduction, the Stx5 protein level 
was on average not reduced in the other Western Blots performed (cf. Figure 18). On the 
other hand, a strong reduction of WRB mRNA level did not decrease the Stx8 steady-
state protein level. The changes observed in Figure 20B in animals 292 and 290 are only 
minor. Interestingly, in the animals with a moderate reduction of WRB at mRNA level 
(Figure 20B, animals 337 and 315), Stx8 displayed a tendency towards increase, which 
was also observed in the blots discussed above (cf. Figure 17, Figure 18). 
 
Figure 20: In isolated hepatocytes of 6 w old Alb-Cre+ animals, penetrance of the WRB knockout at 
mRNA level highly correlated with the change at protein level for Stx5. 
Western Blots for Stx5 (A) and Stx8 (B) were performed with animals showing different knockout grades of 
WRB at mRNA level. The strength of the knockout is given under the blots. ++ represents animals from the 
25th percentile, + animals from the 50th percentile in Figure 8. Bars always show the quantification of the 





Overall, selected substrates of the pathway behaved differently in 6 w old animals. Only 
Stx5 and Stx6 displayed a significant decrease at steady-state protein levels, and Stx6 
changed at mRNA level as well. However, the presence of this effect varied depending on 
the sample type, i.e. total liver homogenate or isolated hepatocytes, in both cases. The 
different extent of the WRB knockout penetrance had an influence on the effect observed 
in Stx5 and Stx6, with a higher penetrance leading to a stronger effect in the TA proteins. 
All other analysed TA proteins remained unchanged. 
To investigate the development of the WRB knockout, the selected TA proteins were 
analysed in samples from older animals as well. In the following chapter I will describe the 
results I obtained from these experiments. 
 
3.7.2 In older animals, the effect of a WRB knockout on TA proteins depends on 
the sample type 
For a complete analysis of the WRB knockout, a possible influence of the WRB knockout 
and the effects involved on substrates of the pathway were analysed in total liver 
homogenate and isolated hepatocytes of older animals. As opposed to 6 w old animals, 
the samples from older animals were only analysed by immunoblotting and no RT-qPCR 
was performed. 
The results obtained from Western Blots performed with samples from older animals 
displayed different results from the experiments with 6 w old animals, but the results as 
well depended on whether total liver homogenate or isolated hepatocytes of older animals 
were used. Analysis of total liver homogenate revealed that three out of five substrates 
showed a significant increase at steady-state protein level in Alb-Cre+ animals compared 
to Alb-Cre- animals (Figure 21A, B). Stx5, Stx6 and EMD were all increased by at least 
50% (Figure 21B). Stx8 showed a tendency towards increase in Alb-Cre+ animals, but the 
changes were not significant (Figure 21B). Only Sec61β was within error completely 
unchanged. 
However, when steady-state protein levels of the same substrates were evaluated in 
isolated hepatocytes of older animals, none of the five substrates showed a significant 
change when comparing Alb-Cre+ to Alb-Cre- animals (Figure 22A, B). This is all the 
more surprising considering that WRB and CAML both displayed a significant reduction at 
steady-state protein level in the same samples (cf. Figure 16). Only Stx5 and Stx8 show a 
tendency to be increased, but this change was not significant (Figure 22B). All substrates 
showed variability in the intensity of their signals on the blot, but these variations were not 
significant. It has to be mentioned that as for the analysis regarding the pathway 
components, the Alb-Cre+ animal, which did not show any obvious in situ phenotype, was 
left out of this analysis too (marked with an arrowhead in Figure 22). 
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Figure 21: In total liver homogenate of older Alb-Cre+ animals, Stx5, Stx6 and EMD were significantly 
increased at protein level. 
Protein extracts from total liver homogenate of older animals were subjected to SDS PAGE and Western Blot 
to analyse the protein levels of different substrates of the mammalian GET pathway. Immunoblotting is shown 
in A. The quantification of the signals in A is shown in B, bars show averages -/+ SEM. For both Alb-Cre- and 
Alb-Cre+ animals, n = 5. Significance levels of significant changes are indicated in B. P-values are as follows: 
Stx5 = 0.007, Stx6 = 0.002, EMD = 0.0005. For Alb-Cre- animals, n = 5, for Alb-Cre+ animals, n = 5. The blots 




Figure 22: In isolated hepatocytes of older Alb-Cre+ animals, steady-state levels of no TA protein were 
significantly affected by the WRB knockout. 
Protein extracts from isolated hepatocytes of older animals were subjected to SDS PAGE and Western Blot to 
analyse the protein levels of different substrates of the mammalian GET pathway. Immunoblotting is shown in 
A. The quantification of the signals in A is shown in B, bars show averages -/+ SEM. For both Alb-Cre- and 





In conclusion, the selected TA proteins showed a different behaviour in total liver 
homogenate and isolated hepatocytes. While in total liver homogenate Stx5, Stx6 and 
EMD significantly increased at steady-state proteins levels, none if the substrates 
displayed a change in isolated hepatocytes of older animals. 
 
The results obtained from the experiments in the two age groups lead to the conclusion 
that the observed effect on selected substrates depends on the age as well as the sample 
type. The penetrance of the WRB in hepatocytes and the mosaic state of the samples 
might have influenced the findings, as has been described for previous results. 
The following table summarises the results concerning the selected substrates for total 
liver homogenate as well as isolated hepatocytes for the two age groups. 
 
 
Table 5: Summary of section 3.7. 
The of different substrates at mRNA or steady-state protein level are shown. á refers to a significant 
increase, â  to a significant decrease and — to no significant change. n/a, not performed. Cells, isolated 
hepatocytes. Hmg, total homogenate 
 mRNA protein 
Stx5 Stx6 Stx8 EMD Sec61b Stx5 Stx6 Stx8 EMD Sec61b 
6 w 
cells — â — — — — â — — — 
hmg n/a n/a n/a n/a n/a  — —  n/a 
older 
animals 
cells n/a n/a n/a n/a n/a — — — — — 
hmg n/a n/a n/a n/a n/a á á — á — 
 
 
The analysis of steady-state protein levels by Western Blot indicated an influence of the 
hepatocyte-specific WRB knockout on selected substrates of the GET pathway. To further 
characterise this effect, I carried out immunofluorescence experiments to gain more 




3.8 WRB knockout in hepatocytes influences Stx5 subcellular 
localisation 
To investigate subcellular localisation of selected substrates, primary hepatocytes were 
isolated and used for immunofluorescence. Unfortunately, immunofluorescence for the 
pathway components and some of the substrates could not be performed due to a lack of 
suitable antibodies. While all antibodies worked very well for Western Blots, only very few 
could successfully be used for immunofluorescence. 
In isolated hepatocytes, the protein level of selected substrates changed upon WRB 
knockout only in 6 w old animals (cf. Table 5). Immunofluorescence was therefore 
performed with isolated hepatocytes from 6 w old animals. After plating and fixation, the 
cells were stained for Stx5 or Stx8, always co-staining with GM130, a marker of the Golgi 
apparatus (Marra et al., 2001). 
Immunofluorescence analysis showed a clear difference in the presence and/or 
localisation of Stx5 in hepatocytes from Alb-Cre+ animals compared to Alb-Cre- animals 
(Figure 23). In cells from Alb-Cre- control animals, Stx5 displayed typical Golgi staining, 
resembling the one of GM130, with a very clear and bright signal (Figure 23A, C). In cells 
from Alb-Cre+ animals on the other hand, Stx5 was more or less absent in most of the 
cells (Figure 23B). In the cells that did show some signal, the pattern did not resemble the 
typical Golgi staining of GM130 (Figure 23D). 
In contrast to Stx5, Stx8 did not show any clear changes in its localisation or staining 
intensity. The staining in Alb-Cre+ animals resembled the one observed in Alb-Cre- 
animals (Figure 23E, F), which in both cases showed Stx8 to be located around the 
nucleus. The GM130 Golgi staining looked very similar in the Alb-Cre- and Alb-Cre+ 
animals (Figure 23G, H). 
The results obtained from the immunofluorescence in isolated hepatocytes of 6 w old 
animals showed that substrates react with different susceptibility to the knockout of WRB. 
Stx5 was strongly affected in its cellular distribution and presence, in contrast to Stx8, 




Figure 23: The cellular appearance of Stx5 was strongly affected in isolated hepatocytes of 6 w old 
Alb-Cre+ animals. 
Isolated hepatocytes of 6 w old animals were subjected to immunofluorescence staining after fixation. Staining 
was performed for Stx5 (A, B) or Stx8 (E, F). In all cases, a staining for the Golgi protein GM130 was carried 






The correct insertion of membrane proteins is crucial for the normal function of every cell. 
For the different types of membrane proteins, different targeting and insertion pathways 
ensure that the proteins reach their destined membrane. As for the class of TA proteins, 
one major targeting and insertion route is the mammalian GET pathway. The deletion of 
individual components of this pathway results in early embryonic lethality in mice, leading 
to the conclusion that the pathway fulfils essential roles in higher eukaryotes 
(Mukhopadhyay et al., 2006; Tran et al., 2003). However, the same pathway in yeast is 
not essential, although it is linked to proteostatic stress (Metz et al., 2006; Schuldiner et 
al., 2008; Shen et al., 2003). Until now, the reasons behind the indispensability of the 
pathway in higher eukaryotes are unclear. The in vivo client spectrum of the pathway and 
its possible connections to the protein quality control machinery of the cell are poorly 
understood. 
To gain more insight into the role of the pathway in vivo and find out about possible 
substrate dependencies, in this study a mouse model was established in which the 
pathway was disturbed by deletion of WRB, one part of the heterodimeric receptor of the 
mammalian GET pathway, in a hepatocyte-specific manner. This knockout results in a 
substantial liver damage, shown on both macro- and microscopic level. Also on cellular 
level the knockout influences both, pathway components and TA protein substrates of the 
pathway. Depending on whether total liver homogenate or isolated hepatocytes were 
analysed, the results differed. Experiments were performed with mice of two different age 
groups.  I will discuss how the different results obtained may reflect different stages of 
adaptation to the hepatocyte-specific knockout. 
 
4.1 Knockout of WRB in hepatocytes leads to substantial liver 
damage 
So far it was not possible to study the role of the mammalian GET pathway in vivo on a 
global level. For the pathway components TRC40 and CAML, a global knockout is early 
embryonic lethal in mice (Mukhopadhyay et al., 2006; Tran et al., 2003). For WRB, this is 
not yet published but results from our lab suggest that a constitutive knockout of WRB in 
heart leads to perinatal lethality in mice. The mouse model established for this study 
displayed a hepatocyte-specific WRB knockout. This was achieved by using the Cre-Lox 
system, which allows a tissue- or cell-specific deletion of a targeted gene (Orban et al., 
1992; Sauer and Henderson, 1990). By expressing the Cre recombinase under the 
Albumin promoter in a mouse line which carries a WRB allele with the targeting sites for 
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the Cre recombinase (LoxP sites) flanking the three middle exons, a hepatocyte-specific 
knockout of WRB was induced (Postic and Magnuson, 2000; Postic et al., 1999). 
Animals with a hepatocyte-specific knockout of WRB were viable, but displayed massive 
liver damage. In situ, the liver of Alb-Cre+ animals already displayed a strongly damaged 
phenotype on macroscopic level. The damage was further investigated by histological 
analysis and blood parameters. Histological analyses were performed to assess any 
changes on tissue level. Blood parameters were analysed with regard to the levels of the 
Alanine Transaminase (ALT) and the Aspartate Transaminase (AST). An increase of the 
serum levels of these enzymes is a typical indicator for liver damage on the cellular level, 
since they are released from damaged and dying hepatocytes (McClatchey, 2002). 
In 6 w old Alb-Cre+ animals, the phenotype on macroscopic level was characterised by a 
rough surface structure and a change in texture of the liver tissue (Figure 3). The further 
analyses of both blood parameters together with histology suggested a very high level of 
liver damage at that age. The blood parameters showed a strong increase of both ALT 
and AST, indicating a high number of damaged hepatocytes (Figure 4). The histology 
revealed the formation of connective tissue structures, and general change in the cellular 
organisation of the liver tissue (Figure 5). Connective tissue formation in the liver is a well-
known reaction to liver damage of any kind, leading to liver fibrosis and in the final stages 
to liver cirrhosis (Friedman, 2000). This process is to current knowledge mainly promoted 
by stellate cells of the liver. Activation of the stellate cells can happen due to injured 
hepatocytes and leads to drastic changes in tissue organisation during the response 
(Friedman, 2000). The high amount of connective tissue present in liver tissue of the 6 w 
old Alb-Cre+ animals and the changed cellular organisation are therefore concluded to be 
a pathophysiological response to damaged and dying hepatocytes. 
In older animals, the macroscopic change of the liver in Alb-Cre+ animals appeared more 
drastic than at 6 w. The surface of the liver was very rough compared to the appearance 
in Alb-Cre- animals, and clear nodules were visible. The histological analysis suggested 
that the nodules were structures containing normal liver tissue encapsulated in connective 
tissue septa (Figure 6). The levels of ALT and AST in older Alb-Cre+ animals were not as 
drastically increased as in the 6 w old Alb-Cre+ animals (Figure 4). Taken together, these 
results suggest that liver damage in the older animals was still present, but not as severe 
as in the younger animals. 
The mouse liver has remarkable regeneration capacities, and a loss of up to 2/3 of the 
liver mass can be tolerated, and regrowth is possible (Fausto et al., 2006). When 
comparing the phenotype of the 6 w old animals with the older animals, the decrease in 
the severity of the liver damage can be explained by constant regeneration of liver tissue. 
The strong damage in the 6 w old Alb-Cre+ animals is a clear indication that a disturbance 
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of the mammalian GET pathway in hepatocytes leads to damage and cell death in these 
cells. But since a knockout with the Cre recombinase usually never reaches 100% 
penetrance, some hepatocytes may evade this fate and can participate in the 
regeneration process. A closer look at the histology further supports regeneration taking 
place already in the 6 w old animals. Regeneration in the liver occurs in two distinct steps. 
First, a cellular hypertrophy takes place, meaning that enlargement of individual cells is 
promoted to cover for a relatively small loss of liver mass. Upon a high loss of liver mass, 
additional regeneration by cell division and proliferation takes place, leading to a more or 
less equal contribution of these two mechanisms to liver regeneration (Miyaoka et al., 
2012). The histology in 6 w old Alb-Cre+ animals displayed signs of both mechanisms. 
Some nuclei appeared to be in the process of mitosis, while at the same time hypertrophic 
hepatocytes were visible (Figure 5). In older Alb-Cre+ animals, no such markers of liver 
regeneration were visible in the sections (Figure 6), but elevated levels of ALT and AST in 
these animals indicate on-going liver damage. Previous studies have shown that fibrosis 
in the liver can regress to a certain extent (Kisseleva et al., 2012; Taghdouini et al., 2015), 
which further supports the observation that the amount of connective tissue seemed to 
decrease with regeneration in the older animals. A positive selection for hepatocytes 
evading the knockout may contribute to the regeneration. Overall, the different 
phenotypes observed in 6 w old animals and older animals can be described as acute 
liver damage in the 6 w old animals and a situation rather resembling chronic liver disease 
or damage in the older animals. 
Furthermore, the transcriptome analysis performed with RNA samples from isolated 
hepatocytes of 6 w old animals provided additional indications for massive liver damage 
and fibrosis as well as on-going regeneration at this age. Upon functional annotation 
clustering of the differentially expressed genes, some of the processes that were highly 
enriched are involved in the mechanisms of liver fibrosis, while others strongly 
implemented liver regeneration. Liver fibrosis includes steps like cytokine production and 
secretion, chemotaxis of stellate cells and leukocyte chemoattraction (Friedman, 2000), 
and all these processes were represented in the clusters shown in Table 3. On the other 
hand, the strong enrichment in cell cycle and cell differentiation processes points toward 
active liver regeneration. Besides this, terms were enriched that are involved in response 
to wounding and stress, which provides further evidence for the massive liver damage. 
Also on single gene level, typical candidate genes involved in fibrosis and regeneration 
were found. Among the top 50 candidates in Figure 7 are e.g. several collagen genes, 
and Tgfbi and Sparc. These have been described as typical tissue remodelling and 
fibrosis genes involved in liver tissue pathology together with other genes not represented 
in the heatmap, but differentially expressed, such as Loxl2 or Tgfb1 (Nakken et al., 2007). 
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Another gene found in the top 50 candidates is the hepatocyte growth factor (Hgf), which 
is one of the driving forces behind liver regeneration together with other growth factors. 
One of them, the heparin-binding EGF-like growth factor (HB-EGF) is a key player in liver 
regeneration (Fausto et al., 2006). HB-EGF is increased in expression as well, though not 
in the candidates of the top 50 heatmap, similar to other factors involved in liver 
regeneration. All these factors involved in liver regeneration and fibrosis are shown in 
Figure 24. The corresponding values can be found in the appendix (Table 9). 
Figure 24: A heatmap for additional genes involved in liver fibrosis and regeneration. 
Candidates that showed differential expression in isolated hepatocytes from 6 w old animals and are known to 
be involved in liver fibrosis and regeneration are summarised in a heatmap. These genes were not among the 





In summary, I was able to show that a hepatocyte-specific knockout of WRB leads to 
substantial liver damage. This liver damage was observable on macroscopic and 
microscopic level as well as in specific blood markers. In 6 w old animals, the expression 
of the Cre recombinase and therefore the deletion of WRB is expected to be at its 
maximum (Postic and Magnuson, 2000). At this age, this leads to acute liver damage, as 
shown in the severely increased level of ALT and AST in the blood and in the strong 
changes observed in the liver tissue. The high regeneration capacities of the murine liver 
explain the viability of the animals despite the apparent loss of hepatocytes, and why the 
histological findings and blood parameters in older animals suggest less liver damage with 
increasing age, resulting in the situation of chronic liver damage. Hepatocytes evading the 
knockout can either grow in size or eventually proliferate to compensate for the damage. 
 
4.2 Penetrance of WRB knockout varies strongly in its extent 
The clearly visible liver damage discussed in 4.1 implies that the knockout took place and 
had a clear effect on the hepatocytes. To prove the knockout, mRNA and steady-state 
protein levels of WRB were checked in isolated hepatocytes of animals of both age 
groups. Since other studies have suggested that WRB and CAML can stabilize each other 
in the membrane (Vilardi et al., 2014), the levels of CAML were assessed as well. In 
addition, the levels of TRC40 were checked to investigate influences of a WRB knockout 
on TRC40. 
While a decrease of WRB at mRNA level was observed in both age groups, a significant 
reduction on steady-state protein level was only detected in the isolated hepatocytes of 
older Alb-Cre+ animals. Interestingly CAML was reduced at steady-state protein level in 
older Alb-Cre+ animals as well. TRC40 was not affected at protein level in either age 
group, but was slightly upregulated at mRNA level in the 6 w old animals (cf. Table 4). 
The mouse line with the hepatocyte-specific activity of Cre recombinase has been 
reported to lead to a nearly 100% effective recombination (according to (Postic et al., 
1999) and material available on the jax.org website). The reduction of WRB at mRNA 
level indicates an active Cre recombinase and successful recombination. Further analysis 
in 6 w old animals revealed that the level of WRB mRNA reduction differed strongly 
between individual animals (Figure 8, Figure 9). The results showed that only if a very 
high reduction of the WRB mRNA level was present, a clear reduction was visible at 
steady-state protein level (Figure 12). It is a well-described phenomenon that mRNA 
levels do not necessarily represent protein levels of their expressed protein (Liu et al., 
2016). Besides, so far nothing is known about exact expression levels of WRB both at 
mRNA and steady-state protein level or the stability of either of the molecules. Possible 
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explanations for the divergence between mRNA and protein levels of WRB are that WRB 
protein is very stable, and that WRB mRNA is sufficient in little copy number to lead to a 
normal expression of WRB. Furthermore, the activation of the Cre recombinase in 
hepatocytes is not taking place simultaneously in all cells, but rather over time. The liver is 
the main hematopoietic organ in the mouse foetus and only over time develops to its 
typical composition with mainly hepatocytes accounting for its mass (Paul et al., 1969; 
Zaret, 2000). The Albumin promoter driving the Cre recombinase is only active in 
hepatocytes. Therefore a progressive expression of the Cre recombinase takes place in 
parallel to differentiation of hepatocytes (Weisend et al., 2009). If WRB expression has 
already taken place in the precursor cell before the Cre recombinase becomes active and 
if WRB is a stable protein, the recombination does not necessarily have to influence WRB 
protein levels immediately. All this can lead to the observed variability in WRB mRNA and 
protein levels in Alb-Cre+ animals. 
In addition to this, the knockout penetrance of a Cre-recombinase never reaches 100%. It 
is likely that a strong selection for the hepatocytes evading the knockout occurs, 
eventually leading to a mosaic composition of the liver with knockout and non-knockout 
hepatocytes in Alb-Cre+ animals. In that case, a constant change in this composition due 
to loss of hepatocytes followed by proliferation would result in fluctuations of the WRB 
mRNA and protein levels depending on the ratio of knockout to evaded hepatocytes. 
This can explain why the WRB steady-state protein level was significantly reduced in older 
animals in contrast to 6 w old animals. In older animals the ratio between hepatocytes 
evading the knockout and WRB knockout hepatocytes still depends on the penetrance of 
the Cre recombinase and a selection process followed by regeneration and proliferation, 
which differ from animal to animal. 
In addition, the fragility of WRB knockout hepatocytes has to be considered. The isolation 
process is harsh due to the Collagenase treatment and mechanical shear during the 
processing steps. The overall impression was that isolated hepatocytes from Alb-Cre+ 
animals were less viable in culture compared to hepatocytes from Alb-Cre- animals. It is 
possible that some knockout cells are already lost during the isolation process. 
However, if a significant reduction of WRB at steady-state protein level takes place, as 
observed in some animals at the age of 6 w and in the older animals, the protein level of 
CAML is decreased as well. This further supports previous findings that the two receptor 
subunits WRB and CAML stabilize each other in the membrane (Vilardi et al., 2014). For 
TRC40, the situation is not as clear as for CAML. The TRC40 mRNA level is slightly 
increased in 6 w old animals, but the mRNA level in older Alb-Cre+ animals and steady-
state protein levels in both 6 w old and older Alb-Cre+ animals remained unchanged. 
Recent findings describe a role for the yeast homologue of TRC40, Get3, as an ATP-
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independent Chaperone under oxidative stress conditions (Voth et al., 2014). A similar 
role for the mammalian TRC40 has yet to be shown, but since oxidative stress is an 
important factor in many liver diseases (Cichoż-Lach and Michalak, 2014) and reactive 
oxygen species (ROS) are involved in fibrosis (Richter and Kietzmann, 2016), it is not 
unlikely that an increase in ROS could lead to upregulation of TRC40. 
Additionally, mRNA and steady-state protein levels of all pathway components were 
analysed in total liver homogenate to circumvent the hepatocyte isolation process. WRB 
mRNA was still reduced in 6 w old Alb-Cre+ animals, while CAML mRNA was slightly 
upregulated in older animals. No further changes at either mRNA or protein level were 
detected. Although under normal conditions hepatocytes make up 80% of the liver mass 
(Paul et al., 1969; Zaret, 2000), the processes involved in liver regeneration after damage 
can include the attraction of leukocytes via chemoattractants (Friedman, 2000; Lalor et al., 
2002). An increase of other cells in the liver could have influenced the analysis performed 
with total liver homogenate. 
 
4.3 Substrates show different susceptibility to a disturbed GET 
pathway 
One of the not fully unravelled aspects of the mammalian GET pathway is its in vivo client 
spectrum and the question whether certain substrates fully depend on the pathway. The 
reason why the pathway components are essential in higher eukaryotes is still unknown, 
but one possible explanation is that a lack of correct targeting for some substrates results 
in the observed liver damage. In yeast, many of the phenotypes occurring after deleting 
the GET receptor could be recapitulated by deleting individual TA protein substrates 
(Schuldiner et al., 2008). The mouse model established in this study provided the 
opportunity to analyse the effects of a receptor knockout in vivo. For this analysis, I 
focussed on selected substrates, which included three SNARE proteins (Stx5, Stx6 and 
Stx8), a protein of the inner nuclear membrane (EMD) and the beta-subunit of the Sec61 
translocon. These TA proteins have been previously published as in vitro or in vivo 
substrates of the mammalian GET pathway (Abell et al., 2007; Pfaff et al., 2016; 
Stefanovic and Hegde, 2007), or have been shown by experiments in our lab to be clients 
of the pathway (unpublished). Furthermore, the highly conserved yeast homologue of 
Stx5, Sed5, is strongly affected in its targeting by deletion of the pathway components in 
yeast (Schuldiner et al., 2008). 
As for the pathway components, effects on the selected substrates were tested in the two 
age groups previously described. When total liver homogenate was used for the sample 
preparation, the results differed comparing 6 w old animals to older animals. In 6 w old 
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Alb-Cre+ animals, Stx5 showed a significant decrease at steady-state protein level, while 
it was increased in older Alb-Cre+ animals, as was Stx6. The steady-state protein level of 
Emerin however was increased in Alb-Cre+ animals of both age groups (Figure 17, Figure 
21. As discussed previously, the acute liver damage in 6 w old and the chronic liver 
damage in older Alb-Cre+ animals along with the regeneration process may have an 
influence on tissue composition and cellular processes. For Emerin a role has been 
suggested in regeneration of muscle cells in context with its role as binding partner A-type 
lamin (Frock et al., 2006; Pekovic and Hutchison, 2008). It is possible that the 
regeneration and the changed cellular composition lead to the different changes of these 
proteins. 
Upon performing the analysis with isolated hepatocytes, different results were obtained. In 
older animals displaying chronic liver damage, no significant effect at steady-state protein 
levels of any substrate were detected in isolated hepatocytes from Alb-Cre+ individuals. 
On average, effects in isolated hepatocytes of 6 w old animals were only observed in 
Stx6, which showed a significant decrease at both mRNA and protein level (Figure 18, 
Figure 19). Interestingly, when analysing individual animals, different results were 
obtained. In isolated hepatocytes of 6 w old animals that showed a strong reduction of 
WRB at mRNA and steady-state protein level, Stx5 was affected as well and showed a 
decreased steady-state protein level (Figure 20). Immunofluorescence performed with 
isolated hepatocytes from 6 w old animals displayed a clear mistargeting or loss of Stx5 in 
Alb-Cre+ (Figure 23), whereas Stx5 showed a clear Golgi localisation in Alb-Cre- animals. 
A third SNARE, Stx8, did not show a significant change in any of the samples. Overall 
these results suggest that different substrates reacted with a different susceptibility to a 
disturbed GET pathway. 
Both Stx5 and Stx6 have recently been shown to be affected in their localisation upon 
TRC40 knockout in β-cells (Norlin et al., 2016). In the same study, other proteins were not 
as strongly affected, similar to the results obtained in this study. The reasons for these 
differences are not yet fully understood. However, results obtained in a collective and 
collaborative effort to analyse the consequences of WRB knockout in different tissues 
(performed by Jhon Rivera-Monroy and described here for the purpose of discussion) 
further support this observation. Using a different mouse model, an inducible 
cardiomyocyte-specific WRB knockout was realised, and in WRB-deficient 
cardiomyocytes, Stx5 was the most affected substrate as well. It showed reduced steady-
state protein levels and loss of targeting to the Golgi membrane (unpublished data).  
One possible model for the different susceptibilities of the TA proteins towards a disturbed 
GET pathway posits that the TMDs of the substrates have different physico-chemical 
properties influencing their interaction with different chaperones and defining their target 
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mechanism and destination (as reviewed in Borgese and Fasana, 2011). However, as 
part of the same collaborative project to analyse the client selectivity of the mammalian 
GET pathway, the differences between Stx5 and Stx8 regarding their TMDs were 
analysed, and mutagenesis experiments did not deliver any explanation based on the 
differences in the TMD of the two TA proteins (experiments performed by Dr. Fabio Vilardi 
and described here for the purpose of discussion). Changing the order of the amino acids 
in the TMD as well as the hydrophobicity did not alter the observation that Stx5 is more 
susceptible to a disturbed GET pathway than Stx8 (unpublished data). This supports the 
idea that some other factors besides the TMD might play a role in the targeting process 
and explain the differences in how substrates are affected by disturbing the GET pathway. 
Further experiments performed by Dr. Fabio Vilardi suggest that the observed differences 
between Stx5 and Stx8 are caused by their N-terminal cytosolic domains rather than their 
TMDs. The cytosolic domain of Stx5 shows a higher aggregation propensity than the one 
of Stx8 in vitro, suggesting that not exclusively the properties of the TMD, but also of the 
N-terminus influence targeting of TA protein substrates. 
Interestingly, sequence alignments (Figure 25) show that Stx5 and Stx8 share more 
sequence identity (appr. 23%) than Stx5 and Stx6 (appr. 15%), but still Stx8 was found to 
be least affected in this study. Just based on the primary sequence of the proteins, there 
is no explanation for their different behaviour in the Alb-Cre+ animals. This further 
supports the idea that physico-chemical or structural features may be responsible for the 
grade of effect on the different substrates. The observed higher aggregation propensity of 
Stx5 may in vivo present a challenge for the cell, since protein aggregates in the cell can 
be harmful and need to be resolved or degraded by mechanisms such as autophagy 
(Glick et al., 2010; Kaur and Debnath, 2015). In yeast it was shown that upon blocking of 
TA protein targeting to the ER, aggregates of untargeted substrates form in the cytosol 
(Schuldiner et al., 2008). These observations may provide another explanation for the 
sensitivity of different substrates towards a disturbed pathway and an influence on the 
integrity of the cell. If insertion of the TA proteins is hindered, the formation of aggregates 
can add another stress condition in addition to the lack of correctly inserted TA proteins. 
How much a cell is affected by a disturbed GET pathway may therefore depend not only 
on its ability to employ alternative target mechanisms for TA proteins, but also on efficient 
clearance of aggregated substrates. A so far unravelled connection between the TA 
protein targeting function and the protein quality control machinery of the cell, mediated by 
TRC40 may play into this. In yeast, a recent study unveiled a function of Get3, the yeast 
homologue of TRC40, as an ATP-independent Chaperone under oxidative stress 
conditions (Voth et al., 2014), and it is possible that in the mammalian system TRC40 can 




Figure 25: Alignment of Stx5, Stx6 and Stx8. 
An alignment of the two Stx5 isoforms, Stx6 and Stx8 was performed with ClustalO 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The figure was generated with ESPript.cgi, version 
ESPript.cgi 4.0.6b. Sequences are given with their UniProt IDs. Percent identity is given in the table in the 
figure. 
 
However, the reduction of Stx6 on mRNA level can so far not be explained in a 
satisfactory manner.  
Taken together, the results concerning substrate specificity and susceptibility showed that 
while some substrates were not affected in the Alb-Cre+ animals, others displayed 
changes at steady-state level of either protein (Stx5) or mRNA and protein (Stx6) in 
isolated hepatocytes from 6 w old animals. In cells from older animals, these effects were 
no longer present, presumably due to liver regeneration and stabilisation of the liver. 
Effects seen in total liver homogenate of animals in both age groups were most likely a 
result of the underlying regeneration of the liver and a strong mosaic composition of the 
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liver regarding knockout cells and cells evading the knockout as well as other infiltrating 
cell types. 
 
4.4 Expressed TA proteins in the liver and liver damage 
Functional trafficking and a working ER are crucial for the liver to fulfil its functions in 
protein synthesis, secretion and metabolic processes. It is not surprising that the 
disturbance of a pathway that targets proteins to the ER can lead substantial damage 
even up to cell death. The transcriptome data provides evidence that many TA proteins 
are expressed in hepatocytes. Table 8 in the appendix contains a subset of TA proteins 
expressed in hepatocytes of 6 w old animals. 
One large group of the expressed TA proteins consists of SNARE proteins such as Stx2, 
Stx3, Stx5 or Vamp1 and Vamp2 to name a few (see Table 8). Two of them were affected 
in vivo, namely Stx5 and Stx6. Other TA proteins expressed are e.g. Ube2j1and Ube2j2, 
which are both Ubiquitin-conjugating enzymes and are involved in ER associated 
degradation (ERAD) (Araki and Nagata, 2011), or Cytochrome b5, a small hemeprotein 
acting as an electron carrier, e.g. in Cholesterol synthesis in the ER (Porter, 2015). These 
versatile functions covered by TA proteins are needed for cell integrity. A decrease in 
correctly targeted and inserted SNARE proteins may lead to defects in trafficking, and 
insufficient insertion of TA proteins involved in the ERAD machinery may influence the 
protein quality control system of the cell. Additionally, defects in lipid metabolism might be 
a consequence of impaired TA protein targeting. The liver needs all these processes to 
perform its function, and the strong liver damage might be a pleiotropic effect due to many 
of these processes being affected. It has been published that ER stress is involved in liver 
diseases and if the organ cannot cope with the amount of stress, apoptosis is induced 
(Dara et al., 2011; Malhi and Kaufman, 2011). Besides this, is has been discussed that 
ER stress might act as a pro-fibrotic stimulus (Tanjore et al., 2013). 
Furthermore, inefficient targeting of TA proteins could lead to an accumulation of protein 
aggregates in the cytosol, which increases the cellular stress. Additionally the results 
obtained have to be interpreted with regard to the newly identified chaperone function of 
yeast Get3 (Voth et al., 2014). It is possible that TRC40 plays a similar role in the 
mammalian system, and can act as a chaperone to either keep uninserted TA proteins in 
an insertion-competent state, or target them to degradation pathways. 
Taken together, the various functions of the TA proteins expressed in the liver and an 
impairment of the mammalian GET pathway for TA protein targeting can affect the regular 
liver functions at many different points. This pleiotropic scope of the pathway could explain 
the observed acute and eventually chronic liver damage in Alb-Cre+ animals.  
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5 Summary and Conclusions 
In this study, a mouse model was established to investigate the role of the mammalian 
GET pathway in vivo. The Cre-Lox-system was used to realise a hepatocyte-specific 
knockout of WRB, one subunit of the heterodimeric receptor of the pathway. The 
consequences of this knockout on the morphological, histological and physiological 
properties of the liver were characterised. Furthermore, the effect on the expression of the 
main components of the mammalian GET pathway, WRB, CAML and TRC40, was 
analysed. In addition, the impact of the hepatocyte-specific knockout on selected TA 
proteins expressed in hepatocytes was investigated.  
I could show that animals with a hepatocyte-specific knockout of WRB were viable and did 
not exhibit any overall morphological or physiological abnormalities. However, further 
analysis revealed pronounced signs of liver damage. The morphology and structure of the 
liver in situ differed severely from control animals and extensive damage was confirmed 
by histological analysis demonstrating liver fibrosis and elevated plasma levels of the liver 
damage markers ALT and AST. The phenotype changed from 6 w old animals, where it 
resembled acute liver damage, to 10 w old animals, where it was consistent with chronic 
liver damage. 
Transcriptome analysis in 6 w old animals revealed both differential expression of genes 
and an enrichment of functional annotation clusters involved in liver fibrosis and liver 
regeneration. From this I concluded that the liver was damaged to an extent that led to a 
loss of hepatocytes and required liver regeneration. Furthermore, a subset of TA proteins 
expressed in hepatocytes was identified from the transcriptome data. 
Analysis of steady-state mRNA and protein levels of the GET pathway components WRB, 
CAML and TRC40 showed that the penetrance of the WRB knockout in hepatocytes 
varied. My observations support the notion that the strongly negative or even lethal effects 
of WRB knockout on hepatocytes eventually caused a selection of cells, which had 
evaded the knockout. This would result in a mosaic composition of the liver, with a 
constantly changing ratio of knockout hepatocytes to WRB-expressing cells. However, I 
observed that even small yet significant reduction in WRB steady-state mRNA and protein 
levels, lead to a concomitant decrease in the steady-state protein level of CAML, the 
second receptor subunit of the GET pathway. The protein level of TRC40, the cytosolic 
targeting component, remained unchanged. 
 
By analysing a selected subset of TA proteins expressed in hepatocytes, I concluded that 
substrates of the GET pathway vary strongly in their susceptibility towards WRB knockout. 
The two SNARE proteins Stx5 and Stx6 displayed significant reductions of their steady-
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state protein levels. Additionally, I demonstrated an altered distribution of Stx5 in 
hepatocytes by immunofluorescence. 
In conclusion, this study contributed to gaining deeper insight into the physiological scope 
and in vivo client selectivity of the mammalian GET pathway. The results indicate that a 
defect of the mammalian GET pathway in hepatocytes leads to loss of cell integrity and 
viability. I was able to show that in vivo specific substrates were affected by a WRB 
knockout while others remained unchanged. The identification of affected and unaffected 
substrates will enable characterisation of common GET substrate properties and may help 
in unravelling the client spectrum of the pathway in vivo. Furthermore, the results obtained 
have to be interpreted in the light of recent findings in yeast, which show a role of the 
yeast homologue of TRC40, Get3, as an ATP-independent chaperone (Voth et al., 2014). 
Further research has to be carried out to investigate a role of the mammalian GET 
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Table 6: List of all the animals appearing in this thesis. 
All animals used in this thesis are listed with their number, sex and genotype. The age given is the age at the 
point of sacrifice. For Western Blot and RT-qPCR it is indicated whether isolated hepatocytes (cells) or total 
liver homogenate (hmg) was used. TA, transcriptome analysis. 
 
Mouse # Sex Genotype Age 
Western 
Blot 
RT-qPCR TA IF Histology 
Blood 
analysis 
92 f Alb-Cre- 15w 
 
cells  
   
94 m Alb-Cre+ 15w 
 
cells  
   
95 m Alb-Cre- 15w 
 
cells  
   















104 m Alb-Cre+ 13w cells cells  
   





106 m Alb-Cre- 13w cells 
 
 
   










110 f Alb-Cre+ 11w 
 
cells  
   





112 m Alb-Cre- 11w cells cells  
   
113 m Alb-Cre+ 11w 
 
cells  
   
114 m Alb-Cre- 11w cells 
 
 
   





116 m Alb-Cre- 11w cells cells  
   
117 f Alb-Cre+ 12w cells 
 
 
   
118 f Alb-Cre+ 12w cells 
 
 
   
119 f Alb-Cre+ 12w cells 
 
 
   
123 m Alb-Cre+ 12w cells 
 
 
   
131 m Alb-Cre- 11w cells 
 
 
   










138 f Alb-Cre- 14w hmg hmg  
  
x 
139 f Alb-Cre+ 14w hmg hmg  
   
141 f Alb-Cre- 12w hmg hmg  
  
x 










174 m Alb-Cre- 12w hmg hmg  
   
175 m Alb-Cre+ 12w hmg hmg  
   
176 m Alb-Cre+ 12w hmg hmg  
   
177 m Alb-Cre+ 12w hmg hmg  
   
178 m Alb-Cre- 12w hmg hmg  
   
179 m Alb-Cre- 12w hmg hmg  
   






























































































243 m Alb-Cre+ 6w hmg hmg  
  
x 





290 f Alb-Cre+ 6w cells cells  x 
  
292 m Alb-Cre+ 6w cells cells  x 
  
298 m Alb-Cre- 6w cells cells  x 
  
299 m Alb-Cre- 6w cells cells  x 
  
306 f Alb-Cre- 6w 
 
cells  
   
307 f Alb-Cre+ 6w 
 
cells  
   
310 m Alb-Cre+ 6w 
 
cells  
   
313 f Alb-Cre- 6w cells cells x 
   
Appendix 
 84 
314 f Alb-Cre- 6w 
 
cells  
   
315 f Alb-Cre+ 6w cells cells  
   
317 m Alb-Cre- 6w cells cells x 
   
318 m Alb-Cre+ 6w cells cells x 
   
319 m Alb-Cre+ 6w cells cells x 
   
322 f Alb-Cre+ 6w cells cells  
   
323 m Alb-Cre+ 6w cells cells x 
   
325 m Alb-Cre- 6w cells cells x 
   
326 m Alb-Cre- 6w   x    
330 f Alb-Cre+ 6w cells cells x 
   
332 f Alb-Cre- 6w cells cells  
   
333 m Alb-Cre- 6w 
 
cells  
   
334 m Alb-Cre- 6w 
 
cells  
   
337 m Alb-Cre+ 6w cells cells  





Table 7: The top 50 of the differentially expressed genes in isolated hepatocytes of 6 w old animals. 
The 50 genes showing the highest change in differential expression based on the FDR-adjusted p-values are 
listed. Description according to Ensembl.org 
 













































































IQ motif containing GTPase activating 






















platelet/endothelial cell adhesion 
























































































































Table 8: A subset of TA proteins expressed in hepaotcytes from 6 w old animals. 
The list was based on the predicted TA proteins from (Kalbfleisch et al., 2007). Entries were verified via 
Uniprot or via previously quoted publications. Description is according to ensembl.org (BioMart tool). Proteins 
without a p-value exhibited a strong variance in expression. Data has to be considered preliminary.  
 













































































golgi autoantigen, golgin subfamily a, 5 





golgi autoantigen, golgin subfamily b, 












harakiri, BCL2 interacting protein (contains 




































poly (ADP-ribose) polymerase family, 


























stress-associated endoplasmic reticulum 






stress-associated endoplasmic reticulum 




































































unconventional SNARE in the ER 1 


































vesicle-associated membrane protein, 




vesicle-associated membrane protein, 











Table 9: Differentially expressed genes in hepatocytes from 6 w old animals involved in liver 
regeneration or liver fibrosis. 
The transcriptome data was analyses regarding typical genes involved in liver regeneration or liver fibrosis 
that are not represented in the Top50 changed genes. The log2 of the fold change is given along with the p-
value. Description is according to ensembl.org (BioMart tool). 
 
Ensembl Gene ID 
Gene 
name 
Description log2FoldChange padj 
Genes involved in liver regeneration 
ENSMUSG00000028864 Hgf 



















nuclear factor of kappa light 
polypeptide gene enhancer in 





Genes involved in liver fibrosis 
ENSMUSG00000034205 Loxl2 





transforming growth factor, 
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